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Giant dsDNA chloroviruses encode a diverse repertoire of glycosyltransferases
(GTases) and methyltransferases (MTases) that biosynthesize unusual, methylated sugars
independent of their host chlorella-like green algae prompting a reexamination of
glycobiology systems. Unlike most other viruses, the prototype chlorovirus PBCV-1
encodes most, if not all, of the machinery required to glycosylate its major capsid protein
(MCP). The structures of the four N-linked glycans do not resemble any other glycans in
the three domains of life. Here, we investigated the potential involvement of chlorovirusencoded putative GTases and MTases in glycosylation of the viral MCP. First, we aimed
to generate site-directed virus mutants by targeting associated viral genes. We tested
transformation methods using cell wall-degrading enzymes, electroporation, SiC
whiskers, cell-penetrating peptides, and Agrobacterium to generate GT-gene mutations in
the chlorovirus CA-4B. We successfully delivered preassembled Cas9 protein-sgRNA
ribonucleoproteins (RNPs) to macerozyme-treated NC64A cells that resulted in a
frameshift mutation in the CA-4B-encoded gene 034r, a homolog of PBCV-1 GT gene
a064r.
Unable to duplicate these results, we shifted our focus to characterize PBCV-1encoded proteins involved in glycan synthesis. Here, we demonstrated that protein
A064R has three functional domains: domain 1 is a β-L-rhamnosyltransferase, domain 2

is an α-L-rhamnosyltransferase, and domain 3 is a MT that methylates the C-2 hydroxyl
group of the terminal α-L-rhamnose unit (α-L-Rha). We also established that methylation
of the C-3 hydroxyl group of the terminal α-L-Rha is achieved by A061L. Moreover,
genetic and structural analyses indicate the protein coded by PBCV-1 gene a111/114r,
conserved in all chloroviruses, is a GT with three putative domains: galactosyltransferase
(domain 1), xylosyltransferase (domain 2), and fucosyltransferase (domain 3). Hydrolytic
assays supported these predictions suggesting that A111/114R is likely responsible for
the attachment of three of the five conserved residues of the core region of this complex
glycan. These findings provide additional support that the chloroviruses do not use the
canonical host ER-Golgi glycosylation pathway to glycosylate their glycoproteins;
instead, they perform glycosylation independent of cellular organelles using virusencoded enzymes.
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CHAPTER I
INTRODUCTION AND BACKGROUND
1.1. OVERVIEW
This Ph.D. dissertation thesis will introduce chlorovirus-encoded enzymes
involved in the manipulation of carbohydrates that has provided many interesting and
unexpected findings and concepts to the scientific community over the past 40 years. The
aims addressed are twofold. First, to develop a transformation system that supports the
genetic modification of the large dsDNA chloroviruses that infect unicellular Chlorellalike green microalgae. Specifically, to investigate the progression of chlorovirus
glycosylation that takes place independent of its host cell’s biosynthetic machinery using
CRISPR-Cas9 gene editing. And second, to identify chlorovirus-encoded putative
glycosyltransferases (GTases) involved in the unique glycosylation of its major capsid
protein (MCP). Investigations of these sugar-manipulating enzymes will provide the field
of glycobiology with new discoveries and may ultimately answer the central question
about what benefits these viruses have by maintaining their own glycosylation machinery
through evolution.
1.2. PHYCODNAVIRIDAE FAMILY
Conservative estimates suggest there is somewhere between 100,000 to several
million species of algae and that only approximately 40,000 have been identified [1].
Microalgae form the base of the marine food web and their photosynthetic activities
provide an important carbon sink that influences the global carbon cycle and even
climate. The Phycodnaviridae consists of a family of viruses that infect these globally
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important players and comprise a genetically diverse [2], yet morphologically similar,
family of large icosahedral viruses that infect marine or freshwater eukaryotic algae.
These viruses have dsDNA genomes ranging from 160 to 560 kb containing up to ~550
predicted protein-encoding genes (CDSs) [3]. Members of the Phycodnaviridae are
currently grouped into six genera (named after the hosts they infect): Chlorovirus,
Coccolithovirus, Prasinovirus, Prymnesiovirus, Phaeovirus and Raphidovirus. In the
broader evolution picture, phylogenetic analyses of numerous chlorovirus genes indicate
that the viruses most closely related to the chloroviruses are members of the
prasinoviruses. This genus includes viruses that infect the smallest eukaryotic cell
Ostreococcus, and related species in the class Mamiellophyceae [4]. However, the
chloroviruses evolved mainly by gene duplications and losses of genes belonging to large
paralogous families, whereas Micromonas and Ostreococcus phycodnaviruses derive
most of their genetic novelties though horizontal gene transfers (HGT) [5, 6].
The discovery of phycodnaviruses expanded viral diversity among higher plants
given that plants typically are infected by small, plus-stranded RNA containing particles
that only encode a few genes [7]. Their genomes exhibit diverse structures, some with
large regions of noncoding sequence and others with regions of ssDNA. To date, there
are more than 30 species in the Phycodnaviridae, divided among 6 genera, and several
members have been sequenced [2]. The genome analyses have revealed more than 1000
unique genes, with only 14 homologous genes in common among the three genera of
phycodnaviruses sequenced to date [8]. Thus, their gene diversity far exceeds the number
of so-called core genes. Not much is known about the replication of these viruses, but the
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consequences of these infections on phytoplankton have global affects, including
influencing geochemical cycling and weather patterns [9-11].
1.2.A. History of Giant Viruses
The second half of the 20th century was the golden age of virus discovery and
most of the 2,000 recognized species of animal, plant, and bacterial viruses were
discovered during these years [12]. Nevertheless, it wasn’t until the onset of a new
century that introduced new infectious agents, enormous by comparison, that would
challenge our previous guidelines that defined a virus. Their hallmark characteristics,
namely their small size, tiny genomes and parasitic dependence on cellular hosts for
replication, set them apart from all other living things despite their animation. However,
with the onset of giant virus discovery, new descriptions of viruses have straddled life
and nonlife, a divide that usually isn’t difficult to navigate. The discovery of giant viruses
infecting protists pioneered by the isolation of Acanthamoeba polyphaga mimivirus
(APMV), is one of the most unexpected and spectacular breakthroughs in virology in
decades [13-17]. The giant viruses shatter the textbook definition of viruses as
“filterable” infectious agents because their virions do not pass bacterial filters and
obliterate all boundaries between viruses and cellular life forms in terms of size and
number of genes. Indeed, not only are the particles of giant viruses larger than the cells of
numerous bacteria and archaea but also the genomes of pandoraviruses, the current
record holders at approximately 2.5 Mb [18], are larger and more diverse in gene content
than many bacterial and archaeal genomes, from both parasites and free-living microbes
[19]. The recently identified pandoraviruses and pithoviruses [20] are not only observable
under light microscope, but also possess a previously unseen, asymmetrical virion
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structure. These observations highlight the realization that discovery of the extensive
diversity of giant viruses is in its infancy.
Viruses in the family Phycodnaviridae, including the chloroviruses, are proposed
to have an ancient, common evolutionary ancestry with some other large dsDNA viruses
in the Poxviridae, Iridoviridae, Ascoviridae, Asfarviridae, Mimiviridae, Marseillivirdae,
and Pithoviridae virus families. However, many more large DNA viruses are rapidly
being discovered including pandoraviruses, faustoviruses, mollivirus, kaumoebavirus,
cetratvirus, pacmanvirus, and orpheovirus [21] and the evolutionary relationships among
these viruses is just starting to be analyzed [22-24]. Collectively, these giant viruses are
referred to as nucleocytoplasmic large dsDNA viruses (NCLDVs) [22, 25-27] and it has
been proposed that all these viruses should be included in a new order named
Megavirales [28]. Diverse eukaryotes, such as protozoa, vertebrate animals, and insects,
host these viruses. As their name suggests, NCLDVs replicate in both the nucleus and
cytoplasm (phycodnaviruses, asfarvavirus, and iridovirus), or only within the cytoplasm
(poxviruses). They possess large genomes (100 kb to up to 2.77 Mb) and a diverse gene
repertoire that encodes up to 2556 predicted proteins [18]. To put the size of these large
viral genomes into perspective, the smallest free-living bacterium, Mycoplasma
genitalium, encodes 470 proteins [29]. Indeed, their genomes appear somehow closer in
size to a typical cell than any other described virus, encoding proteins that have never
been previously identified in viruses but have closely related eukaryotic homologs.
Although the low levels of genetic similarity among NCLDVs complicate the
precise phylogenetic placement of giant viruses, the relationships between NCLDV
families have been reconstructed using multiple conserved genes [24]. Using five genes
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that are nearly universal in the NCLDVs, a phylogenetic tree indicates that the NCLDVs
form three major branches, with the Phycodnaviridae forming one branch along with the
Mimiviridae and the pandoraviruses [22, 23]. Despite 93% of pandoravirus genes being
previously unknown to biologists [18], the phylogenetic relationships of DNA
polymerase genes from NCLDVs confidently places pandoraviruses with the family
Phycodnaviridae, with an apparent specific affinity with coccolithoviruses like Emiliana
huxleyi virus (Figure 1.1). Therefore, pandoraviruses and phycodnaviruses appear to be
related and phylogenetically distinct from the rest of the giant viruses. Also residing here
in the same ancestral branch is another genus of phycodnaviruses, chloroviruses, that are
the prime focus of this thesis. Although a common evolutionary ancestry of NCLDVs is
generally accepted for at least some of the viruses considered to be NCLDVs,
disagreements exist regarding the role these viruses played in the evolution of eukaryotes.
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Figure 1.1. Maximum likelihood tree of DNA polymerase with genome length and
virion size of various NCLDVs. The maximum likelihood tree shown is a simplified
version of the NCLDV subtree for DNA polymerase adapted from [30], where collapsed
clades in the original tree are represented by single branches. Numbers at each node are
expected likelihood weights from 1,000 rearrangements. The scale throughout the figure
is approximate. Figure from [31].

1.2.B. Chlorovirus Discovery
Reports of virus-like particles (VLPs) in at least 44 taxa of eukaryotic algae have
appeared between the early 1970s and 1991 [32]. These include incidental observations
of VLPs in electron micrographs, for example the first description of VLPs in E.
huxleyi was reported in 1974 [33]. Although these investigators did not publish an
electron micrograph showing VLPs in E. huxleyi, they mentioned that VLPs
in Chrysochromulina mantoniae resembled those of VLPs commonly found in moribund
or dead Coccolithus huxleyi cells (now referred to as E. huxleyi). It was not until 1979
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that a phycodnavirus was even isolated; the virus infected the marine unicellular
alga Micromonas pusilla [34]. However, this report was largely ignored until the early
1990s [35] when high concentrations of viruses in aquatic environments were being
described [36]. These early observations were not further pursued by virologists for
several reasons that include: (i) evidence for the presence of viruses in algae was solely
microscopic and many times it corresponded to a single observation; (ii) in some cases,
algae were field-collected and they were no longer available for study; (iii) cultures were
not axenic; (iv) technical problems regarding virus isolation (e.g., low concentration); (v)
the inability to culture the host [37].
In 1978, Kawakami and Kawakami [38] described VLPs in Chlorella isolated
from the protozoan Paramecium bursaria. However, the virus particles were neither
isolated nor characterized. In the early 1980s, a series of landmark discoveries were made
by Van Etten and Meints [39-42] when they characterized a large virus with polyhedron
structure present in the isolated symbiotic alga Chlorella isolated from Hydra viridis.
They reported that the virus lysed the whole algal population in 24 h and virus particles
were absent in endosymbiotic Chlorella. Further characterization determined that the
virus possessed a 250 kb dsDNA with at least 19 structural proteins, including a 46 kDa
major capsid protein (MCP). Six other hydra Chlorella viruses were isolated within a
short time. Initial restriction fragment analysis of all the viruses that infected
endosymbiotic Chlorella (now referred to as chloroviruses) revealed four different types
of isolates and showed no correlation between genomic composition and geographical
origin of the viruses.
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One of the six genera in the Phycodnaviridae, chloroviruses are icosahedralshaped dsDNA-containing viruses that infect and replicate in certain strains of
unicellular, symbiotic, chlorella-like green algae. Chloroviruses are widespread
in freshwater environments in all parts of the globe and have been isolated from
freshwater sources in Europe, Asia, Australia, as well as North and South America [43].
Chlorovirus titers are variable by season and location, but typically fluctuate between 1
and 100 PFU/mL, although high abundances of up to 100,000 PFU/mL may occur in
some environments. Due to the rich genetic diversity and high specialization of
individual species with respect to infectious range, variations in their ecology are not
unusual, resulting in unique spatio-temporal patterns, which ultimately depend on
lifestyle and nature of the host. As such, titers fluctuate during the year with the highest
titers typically occurring in the spring, followed by another increase in the late fall while
in mid-summer there can be few detectable viruses in the water column [44]. Chlorovirus
genome sequences have also been detected in metagenomes from marine environments
[45] but no chloroviruses have been isolated from these environments.
Known chlorovirus hosts, which are normally mutualistic endosymbionts and are
often referred to as zoochlorellae [46], are associated with the ciliate protozoan
Paramecium bursaria (Figure 1.2a) [38], the coelenterate Hydra viridis [39, 40], or the
heliozoon Acanthocystis turfacea [47]. Four such zoochlorellae and their viruses
are Chlorella variabilis NC64A (NC64A) and its viruses (referred to as NC64A
viruses), Chlorella variabilis Syngen 2–3 and its viruses (referred to as Osy
viruses), Chlorella heliozoae SAG 3.83 and its viruses (referred to as SAG viruses)
and Micractinium conductrix Pbi and its viruses (referred to as Pbi viruses). The
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zoochlorellae are resistant to virus infection when they are in their symbiotic relationship,
because the viruses have no way of reaching their hosts. For example, the zoochlorellae
NC64A lives inside the ciliate P. bursaria in a special perialgal vacuole (Figure 1.2b) that
is surrounded by a host-derived membrane, which protects them from attack by host lytic
enzymes. While an individual protist can harbor up to several hundred algal cells at any
given time, free-floating algae are highly susceptible to chloroviruses, indicating that
such endosymbiosis serves to provide resistance from infection. In this relationship, P.
bursaria can produce glutamine and Mg2+ for the symbiotic algae, and the algae can take
glutamine as a nitrogen source and utilize Mg2+ for chlorophyll-based photosynthesis
[48]. In return, symbiotic algae may provide photosynthetic products, such as fructose,
maltose, and oxygen, to host cells. Previous studies also demonstrate existing nutrient
trading systems between hosts and symbionts (e.g., O2, CO2, maltose and amino acids)
[49].
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Figure 1.2. Light and transmission electron micrographs of P. bursaria with
endosymbiotic chlorella. (a) Differential interference contrast (DIC); (b) Transmission
electron microscopy (TEM); Ma, macronucleus; OA, oral apparatus; Chl, chlorophyll;
PV, perialgal vacuole membrane; CW, cell wall; Mt, mitochondrion; Tc, trichocyst.
Figure from [50].

A phylogenetic analysis of 32 concatenated conserved genes from 41
chloroviruses that infect three zoochlorellae hosts, i.e., 14 NC64A viruses, 14 Pbi viruses,
and 13 SAG viruses, revealed three important features about chlorovirus evolution
(Figure 1.3a): (i) viruses infecting the same zoochlorella host clustered in monophyletic
clades despite being isolated in diverse locations across five continents; (ii) The
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branching pattern of the three main virus clades does not match the phylogeny of the 18S
RNA alignment of their zoochlorellae hosts (Figure 1.3b), which eliminates the simplest
co-evolution scenario whereby the algae and virus lineages separated at the same time;
(iii) The phylogenetic position of virus NE-JV-1 within the Pbi virus clade is the first
representative of a previously unknown subgroup of chloroviruses. The most recently
discovered chlorovirus group, the Osy viruses, are interesting because phylogenetic
analysis of 29 proteins encoded by the 32 conserved concatenated core genes of
chlorovirus Osy-NE5 indicates that this virus resides between two separate phylogenetic
subclades of NC64A viruses (not included in Figure 1.3) [51].
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Figure 1.3. Phylogenies of chloroviruses and algal hosts. (a) Phylogenetic tree shows
the evolutionary relationships between 47 chloroviruses based on amino acid sequences
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encoded by 32 conserved concatenated genes. The Maximum Likelihood tree was
constructed using the MEGA 6.0 software with the Maximum Likelihood algorithm and
default setting. The bar length represents 0.2 substitutions per amino acid site. A recently
characterized Osy chlorovirus species resides between separate phylogenetic subclades of
NC64A viruses (not included); Four Ostreococcus virus sequences served as outgroups to
root the tree. (b) Maximum Likelihood tree of three algal hosts based on 18S RNA
alignment. Figure from [52].

Large amounts of chloroviruses can be produced and assayed by plaque formation
on lawns of algae using standard bacteriophage techniques. This provides a sensitive
bioassay that is still used today. Attempts to culture the zoochlorellae from hydra to serve
as a host for the viruses that infect hydra zoochlorellae were unsuccessful [37]. Given
Chlorella can be grown independently of their symbiotic partners in the laboratory,
permitting plaque assay of the viruses and synchronous infection of their hosts, NC64A
virus Paramecium bursaria chlorella virus-1 (PBCV-1) naturally become the prototype
virus in the laboratory allowing one to study the life cycle of chloroviruses in detail.
Extending behind virological orthodoxy, the chloroviruses, especially PBCV-1 and its
host NC64A, are serving as a flexible model system to address concepts of co-evolution
at the phenotypic and genotypic levels, ecological dynamics, and predator-prey modeling
[53-55].
1.2.C. Prototype chlorovirus Paramecium bursaria chlorella virus-1
Several hundred plaque-forming chloroviruses have been characterized to various
degrees. The genomes of 43 chloroviruses infecting four different alga hosts have been
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sequenced, assembled and annotated [51, 52, 56-59]. Collectively, the viruses encode
genes from 643 predicted protein families; however, any given chlorovirus only has 330
to 416 protein-encoding genes. Thus, the genetic diversity among these viruses is large,
and many of the proteins are unexpected for a virus. With the exception of homologs
solely in other chlorovirus members, about 50% of their protein-encoding genes do not
match anything in the databases. Given the coding capacity of the chloroviruses, it is not
surprising that they encode many unusual proteins. Some of these viruses also have
introns and inteins, which are rare in viruses. The most studied chlorovirus and the first
phycodnavirus to be sequenced was PBCV-1 which infects NC64A [60]. The C.
variabilis 46.2 Mb genome was sequenced [61] and the availability of both host and virus
sequences makes chloroviruses an attractive model system.
Cryo-electron microscopy (cryo-EM) and six-fold symmetry averaging threedimensional reconstruction of PBCV-1 virions at ~26 Å resolution indicated that the
capsid was an icosahedron that is 1900 Å in diameter from point-to-point with a
triangulation number of 169d [62]. The capsid covers a single lipid bi-layered envelope,
which is required for infection [63, 64]. The trimeric capsomers are arranged into 20
triangular facets (trisymmetrons, each containing 66 capsomers) and 12 pentagonal facets
(pentasymmetrons, each containing 30 trimers and one pentamer at each of the
icosahedral vertices) (Figure 1.4a). However, as cryo-EM procedures have improved,
more details have emerged about the structure of the PBCV-1 virion; the virus is much
more complex than the original icosahedral structure suggested.
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Figure 1.4. Cryo-EM structure of PBCV-1. (a) Hexagonal arrays of major capsomers
form trisymmetrons and pentasymmetrons. The unique vertex with its spike structure is at
the top. Capsomers in neighboring trisymmetrons are related by a 60 rotation, giving rise
to the boundary between trisymmetrons. A fiber extends from one of the capsomers in
each of the trisymmetrons. (b) The cryo-EM density (3.5 Å resolution) of PBCV-1 after
removing the MCP so that 14 minor capsid proteins are visible. Each protein is shown in
a different color. (c) Cross section of a five-fold averaged cryo-EM image of PBCV-1
reveals a long narrow cylindrical spike structure at one vertex and the viral internal
membrane (green) surrounding the viral genome asymmetrically (left). Cross section of a
five-fold averaged cryo-EM image of PBCV-1 as the virus is ready to release its DNA
into the host cell (right). (a) is from [63], (b) is from [65], and (c) is from the cover of J.
Virology issue 17, 2012.

Improvement to 8.5 Å resolution and five-fold symmetry 3D reconstruction of
cryo-EM images revealed that one PBCV-1 vertex has a 560 Å long spike-structure
(Figure 1.4a); 340 Å extends from the surface of the virus [63, 64]. The part of the spike
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structure outside the capsid has an external diameter of 35 Å at the tip, expanding to 70 Å
at the base. The spike structure widens to 160 Å inside the capsid and forms a closed
cavity inside a large pocket between the capsid and the membrane enclosing the virus
DNA (Figure 1.4c). Therefore, the internal virus membrane departs from icosahedral
symmetry adjacent to the unique vertex (Figure 1.4c). Consequently, the virus DNA is
packaged non-uniformly in the particle. (This asymmetric packaging of the genome was
reported previously in an ultra-structural study of the Pbi virus CVG-1 [66] and is
apparent in other earlier electron microscopy studies). External “fibers” extend from
some of the trisymmetron capsomers (one per trisymmetron) and are rigid enough to be
resolved with cryo-EM methods; the fibers presumably aid in virus attachment to the host
(Figure 1.4a). The fiber-containing capsomer is always located in the middle of the
second row of capsomers in the trisymmetron.
Recently, a 3.5 Å near-atomic resolution structure of PBCV-1 by cryo-EM was
reported [65]. This resolution was accomplished by correcting for the Ewald sphere effect
in single cryo-EM reconstructions [67]. Otherwise, the technology was stalled at ~4.5 Å
resolution. The 3.5 Å resolution led to the identification of 14 virus-encoded, minor
capsid proteins that form a hexagonal network below the outer capsid shell, stabilizing
the capsid by binding neighboring capsomers together (Figure 1.4b). This minor capsid
protein shell cements most of the gaps between neighboring capsomers and uses
transmembrane helices to mediate inner viral membrane association. The size of the viral
capsid is determined by a “tape-measure” minor capsid protein of which there are 60
copies in the virion. Homologs of the tape-measure protein and some of the other minor
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capsid proteins exist in other NCLDVs. Thus, a similar capsid assembly pathway might
be used by other NCLDVs.
The PBCV-1 genome is a linear ~331-kb, dsDNA molecule with 35 nucleotidelong, covalently closed hairpin termini that exist in one of two forms. The two forms are
complementary when the 35-nucleotide sequences are inverted [68]. Identical ~2.2-kb
inverted repeats flank each hairpin end [69]. The remainder of the PBCV-1 genome
contains primarily single-copy DNA. The GC content of the PBCV-1 genome is ~40%;
by contrast, its host nuclear genome is ~67% GC. The PBCV-1 genome was resequenced in 2012 to correct mistakes in the original sequence that was reported in the
mid-1990s [60]. Using 40 codons as the minimum CDS size and avoiding large overlaps,
PBCV-1 contains 416 CDSs (three outermost rings in Figure 1.5). Of the predicted CDSs,
~50% resemble proteins of known function, including many that are novel for a virus.
The CDSs are evenly distributed on both DNA strands with minimal intergenic spaces.
One exception is a 1,788-nucleotide sequence in the middle of the PBCV-1 genome
encoding 11 tRNAs, which is co-transcribed as a large precursor and then processed to
mature tRNAs [70].
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Figure 1.5. Mapping of the PBCV-1 transcriptome. PBCV-1 genes on the forward and
reverse strands are depicted by red and blue boxes respectively. The green curves in the
interior concentric circles represent the normalized read coverage for each time point (7,
14, 20, 40, and 60 min p.i.) of the experiment in logarithmic scale (base 10). Open boxes
are superimposed onto the read coverage curves to show calculated MRPN values for
each gene. Below the outer circle, red and green triangles indicate the location of
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predicted splice events and polyadenylation cleavage site, respectively. Note: the PBCV1 genome is a linear molecule with inverted repeats and closed hairpin ends that is
depicted as a circle. The two ends are at the 12 o’clock position. Figure from [71].

PBCV-1 and the other chlorovirus genomes contain methylated bases, which
occur in specific DNA sequences [72]. Genomes from 37 chloroviruses have 5methylcytosine (5mC) in amounts ranging from 0.12 to 47.5% of the total cytosines. In
addition, 24 of the 37 viral DNAs contain N6-methyladenine (6mA) in amounts ranging
from 1.5 to 37% of the total adenines [32]. The methylated bases occur in specific DNA
sequences, which led to the discovery that chloroviruses encode multiple 5mC and 6mA
DNA methyltransferases (MTases). Interestingly, the methylated bases are part of the
virus-encoded DNA restriction and DNA modification systems [73]. About 25% of the
virus-encoded DNA MTases have companion DNA site-specific (restriction)
endonucleases, including some with unique cleavage specificities (2 to 4 bp) that are sold
commercially [74, 75]. Prior to the discovery that the chloroviruses encoded enzymes
with DNA restriction endonuclease activity, all known DNA restriction endonucleases
were from bacteria. The purpose of the other virus-encoded DNA MTases is unknown.
One possibility is that they were originally associated with companion DNA
restriction endonucleases that have subsequently been lost in evolution or serve some
other unknown physiological function.
The sum total of chlorovirus-encoded CDSs from 45 analyzed viruses (NC64A,
Pbi, SAG viruses) include ~650 protein families. Any one virus encodes no more than
~400 CDSs, thus the chloroviruses have a lot of genetic diversity. Furthermore, some
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chlorovirus-encoded CDSs have as many as three distinct functional domains, and each
domain encodes an independent enzyme activity. Therefore, the genetic diversity of the
chloroviruses is much larger than the total number of genes. Why chloroviruses need this
large amount of gene diversity and the origins of many of these genes is unknown.
Three-dimensional reconstruction of PBCV-1 in the presence of NC64A cell
walls supports the hypothesis that the virus spike structure first contacts the cell wall
(Figure 1.4c) [76] and that fibers appear to aid in holding the virus to the wall. The
PBCV-1 protein A140/145R, referred to as Vp130, was reported to be involved in
recognizing the host receptor [77] and to be located at a unique vertex [78]. The virus
spike structure is too narrow to deliver DNA into the host and likely serves to puncture
the wall using a virus-associated enzyme(s) (Figure 1.6a) before it is pushed aside.
PBCV-1 attachment to its host receptor is rapid and specific with an adsorption rate of 5
× 10−9/mL/min [79]. The early stages of PBCV-1 attachment are reversible [80]. The
inability to attach to non-host cells is a major factor in limiting chloroviruses’ host range.
The identity of the host receptor, which is uniformly present over the entire surface of the
alga, is unknown but circumstantial evidence suggests that it is probably a carbohydrate
[81].

21

22
Figure 1.6. Proposed replication cycle of PBCV-1 (top) and infection timeline
(bottom). Attachment of PBCV-1 to the algal wall and digestion of the wall at the point
of attachment (a). STEM tomograph showing the close proximity between the viral and
host internal membrane forming a membrane-lined tunnel between the virus and its host
(b). The viral DNA moves to the nucleus where early gene transcription begins at 5 to 10
min p.i. Early mRNAs move to the cytoplasm for translation, and at least some early
proteins presumably return to the viral genome located at or near to the nucleus to initiate
viral DNA replication, which begins ~60 p.i., followed by late gene transcription. Late
mRNAs move to the cytoplasm for translation and many of these late proteins are
targeted to the virus assembly centers (c), where virus capsids are formed, and DNA is
packaged. Mature infectious virus particles virus particles appear in the cytoplasm of the
cell ~45 min prior to virus release. The Chlorella cell membrane and wall lyses (d), and
infectious PBCV-1 progeny viruses are released at 6 to 8 h p.i. (→) Known events; (- ->)
hypothesized events. EM micrographs by Kit Lee. Figure adapted from [82, 83].

PBCV-1 encodes five proteins that degrade potential cell wall polysaccharides
including two chitinases [84], a chitosanase [84], a β-1,3 glucanase [85], and an alginate
lyase-like enzyme [86-88]. Following host cell wall degradation, the virus internal
membrane fuses with the host membrane (Figure 1.6b), forming a membrane-lined tunnel
between the virus and its host [83], leaving an empty capsid attached to the surface. The
virus-host membrane fusion process triggers rapid depolarization of the host plasma
membrane resulting in the release of K+ from the cell, presumably initiated by a virus
encoded K+ channel that is located in the virus internal membrane [89]. The
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depolarization of the host’s cell membrane is also thought to prevent secondary infection
from another virus or secondary transporters. The rapid loss of K + from the host and
associated water fluxes significantly reduce the host turgor pressure, which aids ejection
of viral DNA and virion-associated proteins into the host (Figure 1.6b) [90].
Circumstantial evidence plus microscopic images [83] indicates that the viral
DNA and suspected DNA-associated proteins quickly move to the nucleus taking swift
command of the host transcription machinery. Given none of the chloroviruses encode a
recognizable DNA-dependent RNA polymerase (DdRp) gene, its rapid transit to the host
nucleus supports these observations. RNAseq experiments revealed that ~50 PBCV-1
genes are expressed within the first 7 min p.i. [71]. By 60 min p.i., essentially all of the
PBCV-1 genes are expressed at some level and ~40% of the poly (A+) containing RNAs
in the infected cell are PBCV-1 transcripts. This rapid increase in viral mRNAs probably
involves increased viral transcription together with the selective degradation of host
mRNAs within 5 min p.i., presumably by the PBCV-1 encoded and packaged DNA
restriction endonucleases. Further, host chromatin remodeling is probably involved
because PBCV-1 also encodes and packages an enzyme (referred to as vSET) that trimethylates Lys-27 in histone 3 [91] which likely suppresses host transcription. Not
surprisingly, transcription of host genes is altered within the first 7 min after PBCV-1
infection [92]. This reversal in transcription control from host to virus implies that some
component(s) must facilitate active transport of the virus genome to the nucleus.
Presumably virus DNA synthesis begins in the nucleus before moving to the
cytoplasm. By 4 h p.i., the amount of virus DNA in the cell is at least four times higher
than the DNA in the cells at the time of virus infection. At 3 to 4 h p.i., assembly of
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PBCV-1 capsomers begins in localized regions of the cytoplasm, which become
prominent 4 to 5 h p.i. (Figure 1.6c). These localized regions, called virus assembly
centers or virus factories, consist of host cisternae that are derived from the ER next to
the nuclear membrane [93]. By 5 to 6 h p.i. infectious PBCV-1 progeny accumulates in
the cytoplasm and localized lysis of the host cell membrane and cell wall releases
progeny at 6 to 8 h p.i. (Figure 1.6d). Each infected algal cell releases up to ~1000
particles, of which ~25% form plaques. Mechanical disruption of cells releases infectious
virus particles 30 to 50 min prior to cell lysis, indicating the virus is mature in the cell
and that it does not acquire its glycoprotein capsid by budding through the host plasma
membrane as it is released from the cell [94]. Currently nothing is known about the clock
mechanism that must operate to time the release of the nascent virions; however, the
viruses encode several cell wall-degrading enzymes that presumably function for the
virus to escape the cell. A schematic diagram of the predicted PBCV-1 replication cycle
is reported in Figure 6.
1.3. CARBOHYDRATE MANIPULATING GENES IN CHLOROVIRUSES
Chloroviruses are unusual because they encode enzymes involved in
manipulating carbohydrates [95-97]. These include enzymes involved in making
extracellular polysaccharides, such as hyaluronan and chitin, enzymes that make
nucleotide sugars, such as GDP-L-fucose (GDP-L-Fuc) and GDP-D-rhamnose (GDP-DRha) and enzymes involved in the synthesis of glycans attached to the virus MCPs. This
latter process differs from that of all other glycoprotein containing viruses that
traditionally use the host endoplasmic reticulum (ER) and Golgi machinery to synthesize
and transfer the glycans. Van Etten et al. (2017) [97] listed putative chlorovirus genes
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involved in carbohydrate metabolism, which are encoded by the 43 chloroviruses whose
genomes have been sequenced, in Tables 1.1-1.3. Recombinant proteins have been
produced from some of these genes, and the proteins have been characterized (indicated
in bold in the tables). When some of the genes were initially cloned and the recombinant
proteins characterized, the genes were hybridized to many other chlorovirus genomes by
dot blots to determine the distribution of the genes.
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Table 1.1.
Chlorovirus encoded enzymes involved in the synthesis of polysaccharides

1 Hyaluronan

synthase; 2 chitin synthase; 3 chitin binding proteins, except for the chitinase
proteins involved in degrading polysaccharides; a the recombinant protein has the
predicted activity. The numbers refer to the protein names, and the R and L refer to the
strand orientation. From Van Etten et al. Viruses (2017).
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1.3.A. Polysaccharide Synthesizing Enzymes
Three PBCV-1-encoded enzymes, UDP-glucose dehydrogenase (UDP-GlcDH,
gene a609l) [98], glutamine:fructose-6-phosphate amino transferase (GFAT, gene a100r)
[98], and hyaluronan synthase (has gene) [99] contribute to the synthesis of hyaluronan
(hyaluronic acid), a linear polysaccharide composed of alternating β-1,4-glucuronic acid
(GlcA) and β-1,3-N-acetylglucosamine (GlcNAc) residues. UDP-GlcDH and GFAT are
involved in the biosynthesis of hyaluronan precursors. Until the has gene (a098r) was
discovered in PBCV-1, hyaluronan was only thought to occur in vertebrates and a few
pathogenic bacteria, where it forms an extracellular capsule, presumably to avoid the
immune system [100, 101]. Hyaluronan is an essential constituent of the extracellular
matrix in vertebrates and consists of ~10,000 or more alternating GlcA and GlcNAc
residues. Typically, the HAS enzyme is located on the inner surface of the plasma
membrane. The newly-synthesized hyaluronan then moves through the membrane and
cell wall to the extracellular matrix. The identification of these three genes, transcribed
early in virus infection, led to the discovery that hyaluronan lyase-sensitive hair-like
fibers begin to accumulate on the surface of PBCV-1-infected host cells by 15 min p.i.
By 4 h PI, the infected cells are covered with a dense fibrous hyaluronan network [102].
The has gene is present in about 30% of the chloroviruses. Surprisingly, many
chloroviruses that lack a has gene have a gene encoding a functional chitin synthase (chs)
gene. Furthermore, cells infected with these viruses produce chitin fibers on their external
surface [103]. Chitin, an insoluble linear homopolymer of β-1,4-linked GlcNAc residues,
is a common component of insect exoskeletons, shells of crustaceans, and fungal cell
walls. A few chloroviruses encode both chs and has genes and form both chitin and
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hyaluronan on the surface of their infected cells [103, 104]. Finally, some chloroviruses
lack both genes and cells infected with these viruses produce no known extracellular
polysaccharides [102]. The fact that many chloroviruses encode enzymes involved in
extracellular polysaccharide biosynthesis, which require huge amounts of ATP for their
synthesis, suggests that the polysaccharides are important in the viral life cycles.
However, they do not appear to be required for chlorovirus replication in the laboratory.
Furthermore, because all of the chloroviruses, including ones that lack the has and chs
genes, have been isolated from natural sources in recent years, the genes do not appear to
be essential for replication in native environments. Currently, it is not known how or why
the chloroviruses acquired these polysaccharide-synthesizing genes.
1.3.B. Nucleotide Sugar Metabolism Enzymes
Many chloroviruses also encode enzymes involved in nucleotide sugar
metabolism, as well as other sugar metabolic enzymes (Table 1.2). Two enzymes
involved in synthesizing GDP-L-Fuc are encoded by all of the NC64A, SAG and Syn
chloroviruses, GDP-D-mannose (GDP-D-Man) 4,6 dehydratase (GMD) and GDP-4-keto6-deoxy-D-Man epimerase reductase (GMER, also referred to as Fuc synthase) (Table
1.2), comprise a highly-conserved three-step pathway in bacteria, plants and animals that
converts GDP-D-Man to GDP-L-Fuc [105]. In vitro reconstruction of the pathway using
recombinant PBCV-1 GMD and GMER proteins resulted in the synthesis of GDP-L-Fuc
as expected. Unexpectantly, PBCV-1 GMD is unusual because it can also convert the
GMD product into GDP-D-Rha in the presence of NADPH, that is, the enzyme performs
two activities that produces both sugars inside the infected cell [105]. Interestingly, the
chlorovirus ATCV-1 GMD homolog lacks the GDP-Rha forming activity [106]. Both
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Fuc and Rha are in the glycans attached to the PBCV-1 MCP. The Pbi chloroviruses lack
both gmd and gmer genes even though the glycans attached to the MCP from the three
evaluated Pbi viruses have Fuc [107]. Other chloroviruses encode additional sugar
metabolizing enzymes including a UDP-D-Glc-4,6-dehydratase [108] and a putative
Man-6-phosphate isomerase.
Besides the chlorovirus-encoded enzymes described above, the viruses have four
additional genes predicted to encode enzymes involved in sugar metabolism (Table 1.2).
Recombinant proteins have not been produced from any of these genes, and so, it is
unknown if they encode functional enzymes. These putative enzymes include an
acetyltransferase (AT) encoded by all 43 chloroviruses, a D-lactate dehydrogenase (DLD) encoded by 32 chloroviruses, fumarate reductase (FRD) encoded by five
chloroviruses and ADP-ribosyl glycohydrolase (ADP-RGH) encoded by nine
chloroviruses, all but two of which are Pbi viruses. The roles these putative enzymes play
in the viral life cycles are unknown.
1.3.C. Unusual Attachment of Glycans to the Chlorovirus Major Capsid Proteins
Structural proteins of many viruses, such as rhabdoviruses, herpesviruses,
poxviruses and paramyxoviruses, are glycosylated. Glycans contribute to the protease
resistance and the antigenicity of these viruses. Most virus glycans are linked to Asn in
the protein via GlcNAc, although some viruses also have O-linked glycans attached to
either Ser or Thr residues via an amino sugar, usually GlcNAc or N-acetylgalactosamine
(GalNAc). Typically, viruses use host-encoded GTases and glycosidases located in the
ER and Golgi apparatus to add and remove N-linked sugar residues from virus
glycoproteins either co-translationally or shortly after translation of the protein. The virus

34
glycoproteins are then transported to the host plasma-membrane where progeny viruses
bud though the membrane and they only become infectious as they leave the cell [109].
However, unlike the process described above, glycosylation of the chlorovirus MCPs
differs from that scenario because the viruses encode most, if not all, of the machinery for
the process. Furthermore, the glycosylation process occurs in the cytoplasm [96, 97].
The conclusion that the chlorovirus PBCV-1 MCP (Vp54, gene a430l) is
glycosylated by a different mechanism than that used by other characterized viruses
originally arose from antibody studies [110]. Rabbit polyclonal antiserum [111] particles
inhibited virus plaque formation by agglutinating the virions. Spontaneously derived
antiserum-resistant, plaque-forming variants of PBCV-1 occur at a frequency of 10−5 to
10−6. Originally, four serologically distinct classes were identified plus wild type virus;
subsequently two additional antigenic variants have been isolated for a total of six
antigenic variants. Polyclonal antisera prepared against members of each of these
antigenic classes react predominately with the Vp54 protein equivalents from the viruses
in the class used for the immunization. Each of the Vp54 proteins from the antigenic
variants migrated faster on SDS-PAGE than those from the strains from which they were
derived, indicating a lower molecular weight. However, all of the de-glycosylated MCPs
migrated at the same rate on SDS-PAGE, indicating that the size differences were due to
the attached glycans. In addition, the a430l nucleotide sequence in each of the antigenic
variants was identical to the wild-type gene; these results verified that the polypeptide
portion of Vp54 was not altered in the antigenic variants. Western blot analyses of Vp54
proteins before and after removing the glycans with trifluoromethane-sulfonic acid or
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altering the glycan with periodic acid, also supported the notion that the antigenic
variants reflected differences in the Vp54 glycans, not the Vp54 polypeptide [110].
Additional observations supported the concept that PBCV-1 Vp54 glycosylation
was unusual: (1) unlike viruses that acquire their glycoproteins(s) by budding through a
plasma membrane, which results in infectious particles, plaque-forming PBCV-1
particles accumulate inside the host 30–40 min before virus release [112]; (2) all of the
antigenic variants were grown in the same host so the glycan differences are not due to
the host; (3) polyclonal antibodies to Vp54, the MCP, do not react with host
glycoproteins; (4) the PBCV-1 Vp54 protein, like the PBCV-1 encoded GTases, lacks an
ER and Golgi signal peptide; (5) unlike most glycoproteins that exhibit size microheterogeneity, PBCV-1 Vp54 appears homogeneous on SDS-PAGE; in addition, mass
spectrometry analysis only revealed one satellite peak that differed from the main peak
by 140 Da, the approximate weight of either one arabinose (Ara) or xylose (Xyl) residue
[113]; and (6) the ability to easily crystallize Vp54 as a homotrimer provided additional
evidence that the protein is essentially homogeneous [114, 115].
Evidence that the N-linked Vp54 glycans are not attached to the Vp54 protein by
a N-linkage was initially obtained from the X-ray crystal structure of the protein [115].
The structure revealed that the protein had four N-linked glycans at Asn positions 280,
302, 399 and 406 [114]. None of these Asn were located in an Asn-X-(Thr/Ser) sequon
sequence commonly recognized by ER located GTases [116]. This finding also explained
why prior attempts to remove Vp54 glycans with enzymes that cleave traditional Nlinked glycans were unsuccessful. Nandhagopal et al. [114] also reported that Vp54
contained two O-linked glycans. However, re-examination of the X-ray crystal data
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(Figure 1.7) indicated that no O-linked glycans were present in the protein [115], which
agrees with our unsuccessful attempts to detect them by chemical procedures.

Figure 1.7. Structure of a PBCV-1 major capsid protein (Vp54) N-glycans. (a) CryoEM close-up view of PBCV-1 trimers. Shaded-surface representations of the
reconstructions viewed down an icosahedral three-fold axis (triangle). Bar, 100 Å. (b)
Structure of a single PBCV-1 MCP (Vp54). The four glycans attached to the MCP at
amino acids Asn 280 (green), Asn 302 (black), Asn 399 (red) and Asn 406 (blue) are on
the outer surface of the virus. (c) Three of the MCPs are assembled into a capsomer,
viewed from the top. (a) is from [62] and (b,c) are from [117].

1.3.D. Glycan Structures Attached to Chlorovirus Major Capsid Proteins
The structures of the PBCV-1 Vp54 N-linked glycans were reported recently, and
they consist of 8–10 neutral monosaccharide residues, producing a total of four
glycoforms (Figure 1.8) [115]. These structures do not resemble any structure previously
reported in the three Domains of Life. Among their most distinctive features are: (1) the
four glycoforms share a common core structure, and the four glycoforms are related to
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the non-stoichiometric presence of two monosaccharides, L-Ara and D-Man; the most
abundant glycoform consists of nine neutral monosaccharide residues organized in a
highly‐branched fashion; (2) the glycans are attached to the protein by a β‐Glc linkage,
which is rare in nature and has only been reported in glycoproteins from a few organisms
[118-121]; and (3) the glycoform contains a dimethylated Rha as the capping residue of
the main chain, a hyper-branched Fuc residue and two Rha residues with opposite
absolute configurations.

Figure 1.8. Structures of PBCV-1 Vp54 N-glycans. Ara and Man are not stoichiometric
substituents and create four different glycoforms. The two on the left are the most
abundant, and both have Man. The structure at the bottom represents the conserved core
oligosaccharide that is present in all of the chloroviruses studied to date. Residues within
the box are those strictly conserved, while D-Rha (outside the box) is a semi-conserved
element because its absolute configuration is virus dependent. Figure modified from [97].

38
Attempts to fit the Vp54 glycan structures into the original Vp54 X‐ray crystal
structure [114] were unsuccessful and led to a re‐examination of the original structure.
This re‐examination produced a structure that was compatible with the four N-linked
glycan structures (Figure 1.7b). As mentioned above, the revised structure lacks the two
O-linked glycans reported originally.
The PBCV-1 Vp54 has a molecular weight of 53,790 Da. The a430l gene encodes
Vp54 with a predicted molecular weight of 48,165 Da so the combined sugars have a
molecular weight of 5625 Da, which is about the weight of the four glycans. Vp54 was
also reported to have a myristic acid attached to the carboxyl portion of the protein [122].
However, myristic acid has not been observed in any of the recent Vp54 structural
experiments, and so, its status is currently unknown. The structures of the Vp54 glycans
from the PBCV-1 antigenic variants, referred to above, are currently being determined,
and as expected, the structures are truncated forms of the wild-type PBCV-1 glycans.
PBCV-1 particles were reported to have two additional glycoproteins in addition to Vp54
[122]. Both of these glycoproteins react with the PBCV‐1 antibody, and so, the glycan
structures are predicted to be or identical to the glycans associated with Vp54. The gene
encoding one of these proteins (Vp260) was identified (gene a122r). Gene a122r
homologs are common in the chloroviruses, and some of the viruses have as many as five
copies of the gene [123]. The role that Vp260 plays in the PBCV-1 virion is unknown.
The glycan structures of the MCPs from seven more chloroviruses, which
represent all four chlorovirus types, were recently reported (Figure 1.9); collectively, all
of the glycans have a common core region (outlined in Figure 1.8). The common core
region consists of a pentasaccharide with a β-Glc linked to an Asn residue, which is not

39
located in the typical sequon Asn-X-(Thr/Ser). The Glc has a terminal Xyl unit and a
hyperbranched Fuc, which is in turn substituted with a terminal Gal and a second Xyl
residue. The third position of the Fuc unit is always linked to a Rha, which is a semiconserved element because its confirmation is virus dependent. Additional decorations
occur on this core N-glycan and represent a molecular signature for each chlorovirus.
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Figure 1.9. N-glycan structures from seven chloroviruses representing four
chlorovirus types. Substituents in brackets are not stoichiometric. All sugars are in the
pyranose form, except where specified. Virus NY-2A is an NC64A virus, virus Osy-NE5
an Osy virus, viruses ATCV-1 and TN603 SAG viruses and MT325, CVM-1 and NE-JV1 Pbi viruses. Figure from [97].
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1.3.E. Glycosyltransferases
In addition to the two GTases, hyaluronan synthase and chitin synthase previously
described, the 43 chloroviruses collectively encode at least eight putative GTases (Table
1.3). PBCV-1 encodes at least eight putative GTases, some of which, if not all,
participate in glycosylating the virus Vp54 protein [96, 111, 113]; they are scattered
throughout the PBCV-1 genome (not shown in Table 1.3; A071R, and HAS and CHS
proteins). Ongoing experiments have identified the role of three PBCV-1-encoded
GTases with four GT activities that are involved in the synthesis of the glycan (Figure
1.10). Two of the three GTases were previously annotated as GTases, but the third
protein was only identified in a recent study [111]. None of these eight PBCV-1 encoded
GTases have an identifiable signal peptide that would target them to the ER.
Furthermore, with the exception of PBCV-1 GTases A473L (six transmembrane
domains; CESA CelA-like) and A219/222/226R (nine transmembrane domains; CXCX2), none of the remaining PBCV-1 encoded GTases are predicted to have transmembrane
domains. Therefore, these enzymes are expected to be soluble proteins. The genes for the
PBCV-1 encoded GTases are expressed early during PBCV-1 infection [124]. Thus,
assuming the enzymes are stable, they would be available for adding sugars to the Vp54
glycans during virus replication.

42

Figure 1.10. Structure of the glycan attached to the chlorovirus PBCV-1 major
capsid protein (Vp54) with the predicted PBCV-1 encoded glycosyltransferases. The
sugar Man and Ara connected by the dashed lines are nonstoichiometric substituents. The
black box encloses the conserved pentasaccharide core structure common to all
chloroviruses analyzed to date. The black labeled enzymes have been shown to carry out
the listed reactions by examining the end products by NMR. The red labeled enzymes
have been shown to carry out the listed reactions by the GloTM assays. Note that protein
A064R has 3 domains, each with an independent activity.

Now that structures of the glycans from the chlorovirus MCPs are becoming
available, one can begin to characterize the viral encoded GTases biochemically. One
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question that needs to be addressed is: Are the sugars added sequentially to the Vp54
protein backbone or are the glycans initially synthesized independently of Vp54, possibly
on a lipid carrier and then attached to the protein in a single step? A slight variation of
these two possibilities is that the core glycan is synthesized independently of the protein
and then attached to Vp54. Additional sugars could then be added sequentially to these
core glycans [96]. We suspect that this viral encoded glycosylation pathway represents a
previously undescribed pathway, possible even a pathway that existed in eukaryotes prior
to the ER and Golgi glycosylation pathway [102].
In the chapters to follow, this thesis will address individual PBCV-1 encoded
GTases and MTases that participate in the synthesis of the unique glycoforms that
decorate the virus Vp54 protein independent of the host microalga Chlorella. One by one,
we will unpack each virus-encoded enzyme with evidence supporting its confirmed or
predicted role in glycan synthesis (Figure 1.10). Of the eight GTases encoded by the 43
chloroviruses, only two of them, homologs of PBCV-1 A111/114R and A075L, are
present in all of the viruses, and so, they are predicted to be involved in the synthesis of
the core glycan structure. A111/114R is especially interesting because it is predicted to
have three GT catalytic domains. Similarly, PBCV-1 encodes another three-domain
protein (A064R) that performs three different functions; however, it is not coded by any
other chlorovirus for which the glycan structures are already known. The following
results strongly suggest that GT diversity is in its infancy of discovery. Ultimately,
further investigation of chlorovirus glycosylation will provide the field of glycobiology
with new discoveries and may ultimately answer the central question about what benefits
these viruses have by maintaining their own glycosylation machinery through evolution.
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1.4. GENETIC MODIFICATION OF CHLOROVIRUSES
Generating recombinant viruses require a pliable host. Unfortunately, reverse
genetic manipulation of NC64A genomes is currently not possible and therefore directed
modification of chloroviruses has yet to be achieved. To overcome this transformation
bottleneck, we tried to develop a transformation system to generate stable site-directed
chlorovirus mutants by targeting virus GT-genes to investigate their potential
involvement in chlorovirus glycosylation. GT-genes were targeted simply because we
developed an antibody-based selection scheme, described below, that can discriminate
between wildtype and variant glycans attached to the MCP. Having the ability to carry
out molecular genetic modifications of chloroviruses, with genomes of 290 to 370 kb,
would help elucidate the function of both known and unknown, novel virus-encoded
proteins. However, to date, only a few algal species and essentially none of their viruses
have been genetically manipulated due to inefficient genome editing methods. Of
particular note has been the recalcitrance of NC64A to genome modifications. Therefore,
the development of heterologous gene expression tools for the viral Chlorella-like green
algal hosts would be an important accomplishment.
More broadly speaking, genetic modification of chloroviruses would provide
functional insight into the unusual chlorovirus encoded proteins mentioned previously
such as hyaluronan synthase, potassium ion channel protein, five polyamine biosynthetic
enzymes, and as addressed in this thesis, GTases. Furthermore, adoption of a reverse
genetics system would also allow the exploration of formerly characterized proteins
having potential scientific and economic benefit. For example, chlorovirus genes encode
commercially important enzymes such as DNA restriction endonucleases and contain
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elements for genetically engineering other organisms. Examples include viral promoter
elements that function well in both monocots and dicots of higher plants, as well as
bacteria [125, 126], and a translational enhancer element that function in Arabidopsis
[127]. Chloroviruses have some of the smallest, most primitive forms of highly complex
proteins that exist in higher organisms serving as a simplified fossil template to study
biochemical models for mechanistic and structural studies [128]. Therefore, the
development of a successful and reproducible chlorovirus procedure for achieving
genetic modification would accelerate the exploration of these microalgae and their
viruses for a broader range of scientific investigations and biotechnological applications.
Such an achievement would be a major step forward.
The studies described here were based on harnessing the RNA-programmable
CRISPR-Cas9 reverse-genetics pipeline, a bacterial immune system that has been
repurposed for genome engineering, to induce mutagenicity and recombination in
chloroviruses. This fast and easy genome editing strategy has accelerated research in
many fundamental and applied disciplines by allowing the dissection of complex gene
interactions and the construction of new pathways through synthetic biology. If we were
successful in using the CRISPR-editing system in chloroviruses, we could knock out a
variety of virus-encoded genes to observe what effect they would have on virus
replication.
1.4.A. Transformation of Green Microalgae
Microalgae and their viruses are receiving increasing attention for their potential
usefulness in a number of industrial applications, including bioremediation and the
production of high-value specialty chemicals [129, 130]. The ability to genetically
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engineer chloroviruses, in order to study and eventually manipulate their metabolic
pathways, would greatly enhance the utility of microalgae-chlorovirus counterparts as
scientifically and industrially important organisms. Considering no current reverse
genetics system exists in either Chlorella or chloroviruses, we are equally limited in the
capacity to either characterize gene function or exploit unique virus-encoded proteins.
With the advent of CRISPR technology and the ongoing discovery of new giant viruses
and their annotated genomes, we are armed with resources that have yet to be married. A
significant barrier to genetic transformation in chloroviruses is the inaccessibility of its
host green alga to genetic manipulation.
Since microalgal cells are not able to take up exogenous DNA by nature, several
genetic techniques have been developed for this purpose. Classical mutagenesis has been
used for the creation of random mutations and a more directed approach to generate
specific insertions, deletions or substitutions into the host strain in order to produce the
desired phenotype [131]. Among transformation methods for the delivery of exogenous
DNA, the most common techniques are electroporation, Agrobacterium tumefaciensmediated transformation, ballistic systems and agitation with glass beads [132-135].
Although, most of these techniques have been proven to work with great success in
model strains such as Chlamydomonas reinhardtii, Phaeodactylum tricornutum,
Scenedesmus, Ankistrodesmus and some Chlorella sp. [136, 137], there is a lack of
efficient and stable transformation techniques that can be applied to a broader range of
microalgae strains.
Genetic engineering of microalgal strains is difficult due to the great diversity of
species with a variety of cell sizes, cell wall structures and composition and, likely,
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unique responses to foreign DNA [138]. Like plant cells, Chlorella cells are surrounded
by a rigid outer cell wall composed of polysaccharides with a variety of sugars as well as
lesser amounts of protein and lipid that presumably makes them more difficult to
transform [139]. DNA delivery can be challenging since DNA has to be transferred
through the cell wall, plasma membrane and nuclear membrane Moreover, the cells have
to be able to survive the chemical or mechanical treatment. Therefore, particular methods
are needed for specific strains and, thus, a broader range of genetic tools have to be
developed.
In order to transform Chlorella, various methods including glass beads [140],
Agrobacterium tumefaciens-mediated transformation [141-143], PEG [144],
protoplasting [145, 146], and electroporation [147-149] have been developed till now.
Among these, as a preferred and efficient method, electroporation has also been applied
to transform various microalgae, such as Chlamydomonas reinhardtii [132], Scenedesmus
obliquus [150], and Nannochloropsis sp. [151]. Electroporation became a successful
genetic tool for the transformation of several microalgal species [132, 152], however the
protocol optimization is often challenging, time-consuming and most importantly, only
proven in selected Chlorella species (C. ellipsoidea, C. vulgaris, C. minutissima, C.
zofingiensis and C. pyrenoidosa) [153]. Microalgal species have a different resistance to
transformation and thus are more or less prone to take up and incorporate exogenous
molecules into their genomes. Moreover, viability can decrease rapidly when high
voltages are applied and variations in DNA fragment lengths or macromolecule sizes can
also decrease the transformation efficiencies [152].
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Less traditional methods of microalga-transformation are being explored with
some success. Karas et al. (2015) [154] and Diner et al. (2016) [155] showed that
episomal plasmids containing a yeast-derived centromeric sequence CEN6-ARSH4-HIS3
can be transferred by conjugation from E. coli strains to the diatoms Thalassiosira
pseudonana and Phaeodactylum tricornutum. Recently, Munoz et al. (2019) [156]
reported an efficient and stable transformation of the green microalgae Acutodesmus
obliquus and Neochloris oleoabundans by transferring exogenous DNA from E. coli via
conjugation.
1.4.B. CRISPR-CAS9 Genome Editing of Microalgae
The CRISPR-Cas9 system is a bacterial immune system that has been repurposed
for genome engineering enabling researchers to manipulate the genome of cells [157159]. This fast and easy genome editing system has accelerated research in many applied
disciplines allowing the dissection of complex gene interactions and the construction of
new pathways through synthetic biology. Presently, most industrial researchers prefer
CRISPR technology for algal genome engineering, since it can be used as versatile tool
for editing a single gene or even a complete metabolic pathway in shorter time than other
classical genome engineering approaches [160]. Despite algal genome editing being in
early-stage of development, major progress has been made in demonstrating proof-ofconcept of genome editing using the type-II CRISPR system [161].
Targeted genome editing using RNA-guided endonucleases is an emerging tool in
algal biotechnology. After successful establishment of the CRISPR-Cas9 system in
animal and plant cells, this technology is being evaluated in a variety of algal cells.
Recently, CRISPR-Cas systems have been widely used to manipulate the genome of both
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freshwater and marine microalgae [162]. A general overview of different algae and genes
edited by the CRISPR-Cas9 technology, transformants screening procedures, and Cas9induced double-stranded break repair mechanisms is provided in Table 1.4 and discussed
in detailed as follows. CRISPR technology has been demonstrated in microalgae
including diatoms to manifest the function of the particular gene(s) and developing
industrial traits, such as improving lipid content and biomass productivity [163].
However, application of Cas9 for algal genome engineering is in preliminary stages. As
noted above, initial success has been achieved with a few model green algae
(Chlamydomonas, Nannochloropsis, Phaeodactylum etc. [163-165]). Cas9-driven
systems have been widely used in most of the studies for targeted knock-in, knock-out
and knock-down of targeted genes in these algae [164, 166]. Development of methods for
targeted genome editing of new strains of microalgae through CRISPR–Cas9 technology
requires significant effort in optimizing DNA delivery methods and improving editing
efficiencies.
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Different CRISPR-Cas-systems-mediated transformation have been reported in
the model green alga, C. reinhardtii. The first attempt to modify target genes in the
genome of C. reinhardtii was made in 2014 [167]. Unfortunately, the implementation of
CRISPR-Cas9 in C. reinhardtii was not as straightforward or as efficient as in other
model organisms. Previous studies showed highly inefficient gene editing in C.
reinhardtii using conventional Cas9 and single guide RNA (sgRNA) genes which yielded
only one colony with a modified target locus per 1.5 × 109 initial cells used for
transformation [167]. From there, several research teams have developed different
strategies and methods to transform C. reinhardtii cells either by experimenting with
CRISPR systems [168], transformation techniques [169], and even by modifying
CRISPR-associated protein used for the purpose [170]. Altogether, these studies showed
that different factors and parameters need to be considered for successful CRISPR
modification in green algae.
The use of circular recombinant plasmids for CRISPR transformation has been a
standard method in related research. This plasmid-based approach (Figure 1.11a)
employees a suitable plasmid backbone into which has been inserted the Cas9 gene
encoding for its protein and a gene encoding a sgRNA that will hybridize with the target
gene. After that, the plasmid is digested and linearized with a restriction endonuclease
enzyme(s) and integrated into the microalgae’s genome following genetic transformation
(usually via electroporation). Cas9 protein, guided by its sgRNA, then induces a DSB
(double-strand break) and potential disruption of the targeted gene. An alternative
approach that avoids many complications inherit in using Cas9 and sgRNA genes is the
use of ribonucleoprotein (RNP)-mediated CRISPR genome editing or the also called
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DNA-free CRISPR (Figure 1.11b). This direct delivery of RNPs alleviates difficulties
with protein expression in cells in which common eukaryotic promoters are not expressed
well. Indeed, this method does not require the delivery of foreign DNA. In addition, the
Cas9-sgRNA RNP is degraded over time - thus limiting the potential for off-target
effects.
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Figure 1.11. Schematic representation on approaches used for CRISPR-Cas9
system-based algal genome engineering. (a) Integration vector-based approach that
results in Cas9–sgRNA nuclease complex formation within an algal cell followed by
double strand DNA cleavage and gap repair by NHEJ or HDR. NHEJ-based gap repair
most often results in insertion or deletion of nucleotide bases (indels) and this mutation in
the target gene often results in gene silencing. HDR-mediated DNA repair requires donor
DNA with homology to the target DNA that allows homologous recombination and
insertion of new DNA sequences into the target gene (i.e., knock-in mutations). (b) In the
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RNP-based approach, purified Cas9 protein and laboratory synthesized sgRNA are
assembled in vitro to form a CRISPR-RNP complex. These complexes are then
transformed in competent cells to create gene knock-out mutants. If DNA fragments
homologous to the target gene are supplied along with the Cas9/RNP, HDR-directed gene
modification (i.e., gene knock-in) can occur. Figure from [162].

High-efficiency protocols for transformation using CRISPR-Cas9 plasmid-based
approaches and Cas9/RNPs have been developed for genome engineering of
photosynthetic microalgae [164, 171]. Recently, a plasmid-based gene-within-a-gene
(Cas9 gene containing an artificial intron with an inserted sgRNA encoding gene)
construct was designed and found to be functional in both C. reinhardtii and tobacco
cells [168]. The authors reported comparatively higher (3 × 10−7) transformation
efficiency for the FKB12 gene. An arginine auxotroph (arg7-8) was co-transformed with
Cas9-intron sgRNA and 80 nucleotides ssDNAs complementary to the argininosuccinate
lyase (ARG) gene, and arginine prototrophs were isolated at much higher efficiency.
When the authors used a ssDNA oligonucleotide designed to appropriately modify the
acetolactate synthase (ALS) gene and supplied it along with a Cas9 gene-within-a-gene
construct targeting the ALS gene, they were able to create a sulfometuron methyl
herbicide-resistant strain of C. reinhardtii [168].
There are a number of reports in which Cas9-RNP-based approaches have been
used for algal genome engineering. This technology utilizes purified Cas9 protein and in
vitro synthesized sgRNA. The Cas9 protein and sgRNA are pre-assembled in vitro, and
directly delivered to algal cells either via electroporation or by biolistic method [166,
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172]. In C. reinhardtii, Cas9 RNPs comprising Cas9 protein and sgRNAs were directly
delivered to the cells by electroporation and created targeted mutations in multiple loci
[166, 173]. RNP-based approaches have also been used to generate more robust strains of
the industrial alga Coccomyxa as a biofuel cell factory [174]. RNP-based approaches
have unique advantages and are comparatively simpler than plasmid-based approaches.
For example, vectors having strong constitutive promoters for Cas9 expression which
often results in continuous expression and higher production of Cas9 inside the cells.
Higher concentration of Cas9 may kill the chassis organism by creating a toxic
environment (e.g. by creating an abundance of non-specific DNA cleavages and/or
causing a lethal level of off-target mutations). Cas9-sgRNA complex used in this
approach requires stringent quality control steps. It is especially important to demonstrate
in vitro DNA cleavage activity at the desired target site on a PCR amplified target DNA.
Optimization of sgRNA and Cas9 concentration for assembly of functional RNP and
development of a robust transformation/RNP delivery system in cells are critical in using
this approach. Indeed, transformation of in vitro assembled RNP complex into algal cells
requires series of optimization to achieve high transformation efficiency. One of the key
considerations for algae competent cell preparation is growth phase and density of
cultures which may vary from strain to strain. To our knowledge, overnight grown
cultures at 0.3–0.5 OD600 are comparatively suitable to achieve higher transformation
efficiency in Chlamydomonas and Chlorella. Optimization of electroporation methods is
also specific for different strains. In C. reinhardtii, electroporation is mostly used for
successful and high-efficiency transformation [167].
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CHAPTER II
CHLOROVIRUS GENETIC TRANSFORMATION
2.1. OVERVIEW
The overall goal of this research aim is to develop a transformation system that
supports the genetic modification of the large dsDNA chloroviruses that infect unicellular
Chlorella-like green microalgae. Specifically, we aim to leverage CRISPR, an RNAguided gene editing technology, to investigate the progression of chlorovirus
glycosylation that takes place independent of its host cell’s biosynthetic machinery. The
ability to genetically engineer chloroviruses, in order to study and eventually manipulate
their metabolic pathways, would greatly enhance the utility of microalgae-chlorovirus
counterparts as scientifically and industrially important organisms. Considering no
reliable current reverse genetics system exists in either Chlorella NC64A or
chloroviruses, we are equally limited in the capacity to either characterize gene function
or exploit unique virus-encoded proteins. In the advent of CRISPR technology and the
ongoing discovery of new giant viruses and their annotated genomes, we are armed with
resources that have yet to be married.
A significant barrier to genetic transformation in chloroviruses is the
inaccessibility of its host green alga to DNA or protein uptake. Like plant cells,
Chlorella cells are surrounded by a rigid outer cell wall composed of polysaccharides
with a variety of sugars as well as lesser amounts of protein and lipid that presumably
makes them more difficult to transform. To address these limitations, we developed a
series of protocols with an original selection scheme designed to introduce exogenous
DNA and protein in an effort to generate chlorovirus GT-gene mutations. We chose to
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target another NC64A virus for gene editing, CA-4B. CA-4B-encoded 034r is a homolog
of PBCV-1 a064r, that encodes for a highly characterized GT with three domains
involved in protein glycosylation: domain 1 has a β-L-rhamnosyltransferase activity,
domain 2 has an α-L-rhamnosyltransferase activity, and domain 3 is a MT that decorates
one position in the terminal α-L-Rha unit [175]. Based on the low methylation levels of
CA-4B DNA [32], we predict there is less likelihood the CA-4B virion packages
restriction enzymes unlike PBCV-1 and other chloroviruses. Therefore, upon infection of
NC64A cells, we believe delivery of any exogenous cargo, like CRISPR editing-RNA
and Cas protein, is less susceptible to virus-encoded restriction endonucleases.
The overall strategy to modify chlorovirus DNA involved testing a variety of
transformation methods that could support the delivery of preassembled Cas9 proteinsgRNA RNPs to generate a targeted gene cleavage event in the CA-4B putative GT-gene
034r. Transformation methods that were investigated included protocols with cell walltargeting enzymes, electroporation, silicon carbide (SiC) whiskers, and cell-penetrating
peptides (CPP). The RNA-directed selection of a specific 20–22 bp nucleotide sequence
within the target gene 034r by the Cas9/sgRNA complex allows the two nuclease
domains of Cas9 to create a DSB at a predetermined site within the gene of interest.
Repair of the DSB by the error-prone nonhomologous end joining (NHEJ) DNA repair
system can result in gene inactivation (i.e., gene knockout). Alternatively, replacement of
the cleaved DNA segment with a closely related DNA fragment via homologous-directed
recombination (HDR) can result in gene replacement (i.e., gene knockin) or nucleotide(s)
substitution. Previously, single-stranded oligodeoxynucleotides (ssODNs) reportedly
provide 100-fold lower levels of nonhomologous integrations compared with double-
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stranded counterparts [176] and have demonstrated scarless genomic editing capabilities
with reduced unwanted off-target cutting [170]. Adopting this strategy should increase
efficiency of targeted DNA editing and replacement in chloroviruses.
Here, we explored whether targeted DNA cleavage could be used to facilitate
homology-mediated mutagenesis by using a DNA repair template complimentary to the
034r gene. We used tandem co-delivery of a DNA template in the form of ssODN with
Cas9/RNPs to achieve HDR. The ssODN is approximately 80 nt long, designed with
homology arms extending 40 nt upstream and downstream of the sgRNA target in CA-4B
034r, respectively (Figure 2.1). The ssODN contained two critical elements that
permitted selection when incorporated into a mutant virus: (1) a MscI point mutation (T
to A) that converts the native restriction site TGGCCA to AGGCC, and (2) a nucleotide
substitution (C to A) that introduces a premature stop codon (TAA). The HDR event
would remove the MscI restriction site and allow us to verify HDR-mediated insertion by
treating amplicons with the restriction enzyme to test for DNA replacement at the site of
Cas9/RNP-mediated DNA cleavage. Amplicons were subsequently sequenced to confirm
RNP-cleavage. Further, the premature stop codon would eliminate translation of the
protein resulting in a shortened glycan at the MCP surface of newly formed viruses when
infected with wild-type PBCV-1. In turn, these virus mutants would be subject to
antibody selection as described in detail in the subsequent Materials and Methods section.
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Figure 2.1. sgRNA and ssODN designs for targeting CA-4B putative GT-gene 034r.
Top: Cartoon rendering of CA-4B putative GT-gene 034r composed of three domains.
Middle: Design of a Cas9/sgRNA gene targeting CA-4B gene 034r to produce mutant
CA-4B with truncated surface glycans. Shaded gray, sgRNA target site; red TGG, PAM
site; underlined, MscI restriction site. Bottom: Design of ssODN to replace a dinucleotide
in the target gene. The homology arms specific to the gene target are flanking the
nucleotides to be changed (green text). Shaded red, stop codon.

2.2. ALGA AND VIRUS, RNP, AND SELECTION
2.2.A. Materials and Methods
Alga growth conditions. Chlorella variabilis NC64A cells were grown in Bold’s basal
medium (BBM) (3 mM NaNO3, 170 M CaCl2 2H2O, 304 M MgSO4 7H2O, 431 M
K2HPO4, 1.3 mM KH2PO4, 428 M NaCl, 12 M Na2EDTA, 2.2 M FeCl3 6H2O, 1.2
M MnCl2 4H2O, 220 nM ZnSO4 7H2O, 50 nM CoCl2 6H2O, 99 nM Na2MoO4 2H2O,
6.4 M CuSO4 5H2O, 184 M H3BO3) modified by the addition of 0.5% sucrose and
0.1% peptone (MBBM) [94]. All experiments were performed with cells grown to early
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log phase (4 - 7 × 106 cells/mL). Cell cultures were shaken (200 rpm) at 26 °C under
continuous light.
In vitro cleavage assay. Production of chloroviruses PBCV-1, CA-4B and DNA isolation
were performed as described [177, 178]. Target loci were PCR-amplified and purified by
2% agarose gel electrophoresis. Purified Streptococcus pyogenes strain Cas9 (SpyCas9)
and Lachnospiraceae bacterium Cpf1 (LbCpf1) (200 nM) were independently
preincubated with sgRNA (600 nM) in cleavage buffer [1× NEBuffer 3 (New England
Biolabs), 10 mM DTT, 10 mM CaCl2] at 37 °C for 15 min. Target DNA (20 nM) was
added to a final volume of 20 μL. Reactions were incubated at 37 °C for 1 h. Cleavage
reactions were purified by using a MinElute PCR Purification Kit (Qiagen) and then
resolved on 2% agarose gels and imaged on a Gel Doc XR+ and ChemiDoc XRS+
systems (Biorad) (Figure 2.2).
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Figure 2.2. In vitro cleavage assay. The target 034r locus from NC64A virus CA-4B
was PCR-amplified and incubated with preassembled Cas9 and sgRNA RNP complexes
in vitro. The complete in vitro cleavage of the target locus confirmed active RNP
formation. Arrowheads indicate cleaved products. L, ladder.

CA-4B mutant selection using antigenic mutant antibody. NC64A cells were infected
with CA-4B (MOI 5) and incubated for 12 h. Site-directed mutant viruses were selected
with anti-Rabbit IgG magnetic beads (RayBiotech) according to the manufacturer’s
protocol (Figure 2.3a). In summary, rabbit polyclonal antiserum prepared against wildtype PBCV-1 collected from previous antibody studies [110], which also binds CA-4B,
was added to the viral lysate and allowed to bind wild-type virus for 1 h. Goat anti-Rabbit
IgG magnetic beads were incubated with the rabbit antibody solution for 30 min and then
separated by magnets. The unbound viruses were collected and subsequently incubated
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for 1 h with rabbit polyclonal antiserum derived from serologically distinct PBCV-1
mutants that have a mutation in gene a064r, homologous to CA-4B gene 034r, that in
turn produces truncated surface glycans. Goat anti-Rabbit IgG magnetic beads were
incubated again with the rabbit antibody solution for 30 min and then separated by
magnets. After the unbound particulates were washed from the beads, the bound mutant
antibodies were eluted from the beads using the elution buffer. The beads were then
magnetically separated from the eluted solution, and the eluted antibodies coupled to
mutant viruses were removed manually and plaque assayed. Individual plaques were
selected, and target DNA regions were PCR amplified with specific primers. The PCR
products were verified by agarose gel electrophoresis, eluted from the gel and sequenced
using the Sanger method (GENEWIZ).
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Figure 2.3. Recovery of CA-4B site-directed mutants by RNP-targeting. (a)
Workflow of antibody selection for mutant chloroviruses. Following incubation with
034r-targeting RNP, macerozyme-treated NC64A cells were infected with CA-4A (MOI
5). Rabbit polyclonal antiserum (PBCV-1 antibody, green) was added to the viral lysate.
Goat anti-Rabbit IgG magnetic beads were incubated with the rabbit antibody solution
and then separated by magnets. The escaped viruses were collected and subsequently
incubated with antibody derived from serologically distinct PBCV-1 mutants (antigenic
mutant antibody, red) that have shortened surface glycans. Magnetic beads were
incubated again with the antibody solution and then separated by magnets. Bound mutant
viruses were eluted from the beads and plaque assayed. (b) Following antibody selection
for mutant CA-4B, 13 plaques were recovered. Domain 1 of 034r from each virus isolate
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was sequenced. (c) Two indels (red) in 034r from two CA-4B variants (1 and 2) were
detected and sequence verified for site-directed mutagenesis by preassembled Cas9
protein-sgRNA RNPs in the PBCV-1 a064r homologous gene. PAM site, gray. WT,
wildtype sequence.

2.3. ENZYMATIC CELL WALL DEGRADATION
2.3.A. Introduction
Microalgal cell walls are complex and poorly understood [179]. The Chlorella
intraspecies variation in cell walls as well as variations observed in a single strain grown
under different conditions can be dramatic, and thus it is difficult to predict which of the
compounds noted below will be present in any one strain. While some Chlorella species
have only a single microfibrillar layer, others have two layers with the microfibrillar layer
proximal to the cytoplasmic membrane and a mono or trilaminar outer layer [180]. The
cell walls of C. vulgaris and other green microalgae are known to have rigid wall
components embedded within a more plastic polymeric matrix [181]. This matrix is
defined as the fraction that is hydrolyzable in 1 N NaOH or 2 M triflouroacetic acid
(TFA) and contains uronic acids, Rha, Ara, Fuc, Xyl, Man, Gal, and Glc. The rigid, TFAresistant cell wall is either glucosamine or a Glc-Man polymer [182]. The predominant
amino sugar found in the rigid cell wall of Micractinium conductrix Pbi is Nacetylglucosamine present as a chitin-like glycan. Chitin (poly-β-1,4-D-Nacetylglucosamine), a polymer commonly found in shellfish, insects, fungi, worms, and
mushrooms which can be deacetylated, either partially or fully, to produce chitosan
(poly-β-1,4-D-glucosamine). Strong acid (6 N HCl) can hydrolyze the rigid cell wall of a
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Chlorella sp., which removes the acetyl group from N-acetylglucosamine leaving
glucosamine while hydrolysis with strong sulfuric acid fails to release detectable neutral
sugars. This suggests that this strain of Chlorella does not have cellulose in the rigid cell
wall.
Digestion of the rigid wall with chitinase releases N-acetylglucosamine yet
complete digestion requires a chitosanase, which indicates that glucosamine polymers are
also present in the rigid wall of Micractinium conductrix Pbi [183]. Based on these
previous studies, the genus Chlorella was in-part defined as containing glucosamine as
the common dominant cell wall polymer [184]. The neutral cell wall sugars of symbiotic
Chlorella strains contain in decreasing amounts the sugars Glc, Rha, Ara, Man, Xyl, Fuc,
and Gal, respectively [185]. Other than the neutral sugars (25 %), the cell wall contained
15–20 % uronic acids, 10–15 % glucosamine, and 6–10 % protein. This cell wall
composition was reported to be similar to the glucosamine containing cell wall
composition of the non-symbiotic algae C. vulgaris, C. sorokiniana, and C. kessleri;
however, the authors were unable to determine the composition of 30–44 % of the cell
wall [185]. Previously [186], isolated Chlorella NC64A cell walls were analyzed for
component monosaccharides (Table 2.1).
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Table 2.1.
Monosaccharide composition of Chlorella variabilis NC64A cell wall from Meints et al.
Virol. J. (1988).

Sugar

Mole percent

Arabinose
Fucose
Galactose
Glucose
Mannose
Rhamnose
Xylose
Glucosamine

5.3
0.7
9.1
51.3
5.3
16.0
5.5
6.9

Total

100.0

Percent of
Soluble fraction
2.6
0.3
4.5
25.5
2.6
8.0
2.7
3.4
49.6

Enzymatic digestion of algal cell walls has been previously studied as a
methodology to make protoplasts of algal cells usually in cell preparation for genetic
transformation. Protoplasts of C. saccharophila and C. ellipsoidea were made using an
enzyme mix containing cellulase, hemicellulase, and pectinase activities [187]. However,
these green algae, which are presumed not to have an outer layer or sporopollenin (now
known as algaenan), required up to 90 h to display any effect from the enzymes. The cells
became very sensitive to physical pressures, bursting simply from the pressure of a cover
slip placed on a microscope slide. Similarly, protoplasts were made from C. vulgaris K73122 using acromopeptidase, cellulase, chitosanase, gluczyme, and uskizyme; however,
only 88 % of the cells were considered osmotically labile [188]. Protoplasts were also
made in C. ellipsoidea, C. vulgaris, and C. saccharophila using three different enzyme
mixes containing cellulase, macerozyme, pectinase, cellulysin, and driselase, although 7
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of the 12 strains tested showed no protoplast formation with any of the formulations
[180].
In the work presented here, we sought to define the extent of degradation that a
variety of enzymatic activities have on the cell walls of NC64A. As the cell wall provides
the main protective barrier between the algae and its surroundings, a detailed
characterization of enzymes that act on the wall could enable the rational design of an
enzyme cocktail that would allow efficient degradation of the wall and delivery of
CRISPR-targeting cargo. Removal of the wall could allow more efficient transformation
technologies to be developed. Finally, our findings could provide broader insight on the
conversion of these cell wall sugars into a more usable substrate for downstream
processes, or potentially ease lipid extraction from these organisms.
2.3.B. Materials and Methods
Cell wall-degrading enzymes. Achromopeptidase, alginate lyase, -amylase (960 FAU/
mL), chitinase, chitosanase (25.9 U/mL), chondroitinase ABC (5 U/mL), drieselase, galactosidase (1,000 U/mL), -glucosidase, hemicellulase, heparinase II (10 U/mL),
hesperidinase, hyaluronidase, kitalase, laminarinase, lyticase, lysing enzymes from
Aspergillus sp., lysozyme, mutanolysin (10 U/mL), pectinase (3,000 U/mL), pectolyase,
phospholipase A1 (10 kU/mL), phospholipase A2, proteinase K, sulphatase (3.37 mg/mL),
and trypsin were purchased from Sigma. -glucuronidase (140 U/mL) was purchased
from Roche. Neuraminidase (50 kU/mL), -N-acetylhexosaminidase (5 kU/mL), -Nacetylglucosaminidase (4 kU/mL), -1-6 mannosidase (32 kU/mL), -2-3 neuraminidase
(50 kU/mL), 1-2,3 mannosidase (40 kU/mL), and endo--N-acetylgalactosaminidase
(40,000 kU/ mL) were purchased from New England Biolabs (Ipswich, MA). Glusulase
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was purchased from NEN Life Science Products ( Boston, MA) (10,000U sulfatase and
90,000 U -glucuronidase/mL). Zymolyase (10 mg/mL) was purchased from
ZymoResearch (Irvine, CA). Macerozyme was purchased from RPI corp (Mt Prospect,
IL). Cellulase was purchased from Sigma Aldrich (St. Louis, MO). Stock concentrations
of enzymes were 20 mg/mL unless otherwise noted.
Enzyme inhibition assay. To assay growth inhibition due to enzymatic activity, 200 L
of algal cells normalized to an OD750 of 1.0 was mixed with 4 mL of media containing
7.5 g/L agar, which was at 42 °C and poured on a petri plate containing 15 g/L agar.
Once hardened, 10 L of enzyme stock was then spotted on the top agar and plates were
incubated in the light at 26 °C for 5 days. As a negative control for enzymatic activity,
enzymes were heat denatured at 100 °C for 10 min and spotted on plates.
Flow cytometry. Cell permeability assays were performed on the BD FACSAria cell
sorter using ATTOTM 550 labeled Alt-RTM Cas9 tracrRNA (IDT 1075928). One L of
ATTOTM 550 labeled tracrRNA (200 uM) was added, incubated for 2 min, and loaded on
the BD FACSAria where 20,000 cells were imaged. Samples were excited using a 488
nm laser and 660–740 nm (chlorophyll) and 480–560 nm (ATTO) emission data as well
as bright field image data were collected. Populations were gated for in-focus cells and
analyzed for permeability.
NC64A transfection by enzymatic digestion. One mL of cell culture of NC64A (5 ×
106 cells) was taken, centrifuged at 8,000 rpm for 5 min, and the pellet was resuspended
in the same volume of a MBBM in the presence of cell wall-degrading enzymes (Table
2.2) or MBBM only. The culture was incubated for 24 h at 25 °C in continuous light.
NC64A cells were centrifuged and resuspended in a solution (0.8 M NaCl and 0.05 M
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CaCl2). Prior to NC64A cells being tested for transforming activity with RNPs, all treated
cells were previously infected with virus and analyzed by plaque assay to confirm treated
cells retained their permissive qualities required for virus attachment and infection. To
generate target-specific site-directed mutants using RNP complex in NC64A, enzymetreated and nontreated cells were transformed with either Cas9 protein or Cpf1 (200 μg)
premixed with 034r-targeting sgRNA (140 μg). Cas9 and Cpf1 proteins in storage buffer
(20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, and 10% glycerol) were mixed
independently with sgRNA dissolved in nuclease-free water and incubated for 10 min at
room temperature. The cell mixtures were incubated for 15 min at room temperature.
Enzyme-treated NC64A cells were then infected with CA-4B and incubated overnight.
Virus mutants were selected using the same antibody selection assay previously
described. Virus plaques were analyzed by PCR and sequenced to detect Indel mutations
by NHEJ, while 034r amplicons were also incubated with MscI to screen for ssODNmediated HDR.
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Table 2.2.
Growth inhibition of Chlorella variabilis NC64A by a variety of enzymes

Enzyme

NC64A

Cellulase
Chitinase
Chitosanase
Driselase
β-Glucosidase
β-Glucuronidase
Hyaluronidase
Laminarinase
Lysozyme
Lyticase
Macerozyme
Pectinase
Pectolyase
Sulphatase
Trypsin
Zymolyase

−
+++
+
−
−
−
−
+++
+++
+++
+++
+++
−
+
−
−

−, no growth inhibition; +++, complete growth inhibition

2.3.C. Results and Discussion
To access enzyme activity against algal cell walls, we developed a reasonable
throughput growth inhibition assay on agar plates, where the ability to inhibit growth was
compared to heat denatured enzyme. Growth inhibition suggests the enzyme is either
degrading the cell wall during construction or the enzyme interferes with precursor
generation prior to assembly into the cell wall. From a variety of enzymes tested,
chitinase, laminarinase, lysozyme, lyticase, macerozyme, and pectinase had the broadest
effect on Chlorella NC64A (Table 2.2) based on the zone of inhibition around the spotted
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area while chitosanase and sulphatase demonstrated minor growth inhibition by
comparison. Heat denatured enzymes did not impact growth in our assay, indicating the
growth inhibition was due to the enzymatic activity alone and not from other potentially
toxic components of the enzyme preparations (data not shown). In one study [181], 14
different strains of Chlorella were challenged with cell wall-degrading enzymes and no
two strains had the same pattern of inhibition. This large range of sensitivity to various
enzymatic activities illustrates the wide diversity of cell wall composition amongst the
alga Chlorella species. Our results show that in methodologies or processes using intact
algal cells or residual algal biomass, enzymatic treatment can have large impacts on the
permeability of the algal cell walls and may be useful in optimization.
After finding enzymes that inhibited growth, we examined their effects on cell
walls of actively growing cultures. To process a large number of enzymes individually
and in combination, we developed a rapid assay that would give statistically relevant
results. We postulated that degradation of the cell wall may have dramatic effects of the
cell membrane as well, which could lead to an altered permeability barrier. Cell
permeability due to enzymatic disruption of the wall was visualized using an imaging
flow cytometer, the BD FACSAria. To evaluate translocation of the RNP across the cell
wall/membrane barrier, we used the 67mer Alt-RTM CRISPR-Cas9 tracrRNA (IDT) that
has a ATTOTM 550 fluorescent dye attached to the 5’ end. The fluorescent dye allows for
a visual analysis of transfected cells and cell sorting by FACS. During data acquisition,
algal cells were positively defined by their chlorophyll autofluorescence. A minimum
chlorophyll autofluorescence was set to eliminate potential false positives from bacteria
and debris present in the culture. The resultant data were analyzed by setting a minimum
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ATTOTM 550 fluorescent intensity threshold, such that the majority of untreated cells
(Figure 2.4a) had fluorescence intensity lower than the threshold. Cells with a fluorescent
intensity above this threshold were considered permeable to the tracrRNA dye as
indicated by cells pretreated with macerozyme (Figure 2.4b), or vortexed with SiC
whiskers or electroporated prior to FACS (Figures 2.4c and 2.4d, respectively).
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Figure 2.4. FACS dot plot analysis of fluorescently labeled NC64A cells. NC64A cells
were visualized by intracellular incorporation of fluorescently labeled tracrRNA
(ATTOTM 550), (a) without enzyme treatment, or prior to FACS were (b) macerozyme
digested, (c) vortexed with SiC whiskers, or (d) electroporated. Cells were illuminated
with a white LED for bright field and a 488 nm laser for fluorescence. Images were
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collected in the bright field and 480–560 nm emission (ATTOTM 550 fluorescence)
channels. Cell populations with a high fluorescent intensity were gated for in-focus cells
and analyzed for permeability.

We have shown previously that CA-4B reacts with PBCV-1 antibody making it
useful to precipitate wild-type CA-4B virus [32]. In addition, studies involving
spontaneous mutant viruses have demonstrated previously that disruption of PBCV-1
a064r leads to viruses with an altered glycan attached to the MCP and that they are
antigenically different from wild type PBCV-1 [107]. Polyclonal antisera were prepared
against these spontaneous mutants. This allowed us to screen for the suspected a064r
disrupted gene with antibody that specifically recognized viruses with this mutation.
Following incubation with the serologically distinct antigenic antibody, the putative
mutant precipitate was eluted, and plaque assayed (Figure 2.3a). The resulting plaques
were subsequently verified by DNA sequencing of domain 1 from 034r using appropriate
PCR primers. Two isolated plaques showed separate indels at the target site supporting
evidence of site-directed mutagenesis by RNP-targeting in the PBCV-1 a064r
homologous gene, CA-4B 034r (Figure 2.3b and 2.3c). These results demonstrate
successful delivery of preassembled Cas9 protein-sgRNA RNPs that resulted in
frameshift mutations in the CA-4B-encoded gene 034r. However, despite exhausting a
number of trails and alternative enzyme combinations, we were unable to duplicate these
results. It is unlikely detection of the mutant virus DNA was due to erroneous sequencing
given all samples were sequenced in triplicates with consistent readings.
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All attempts at producing HDR using ssODNs to remove the native MscI
restriction site in 034r were unsuccessful. Amplicons of the putative GT-gene from
recovered CA-4B plaques after antibody selection were incubated with MscI. Digestion
of virus DNA produced DNA fragments consistent with an intact MscI site (restriction
digestions not shown). The conservation of the restriction site demonstrates no evidence
of ssODN-mediated HDR.
One possible explanation for obtaining the RNP-mediated NHEJ event in CA-4A
DNA is macerozyme successfully eroded the alga cell wall, promoting cell permeability,
allowing the entrance of the RNP-targeting cargo (Figure 2.4b). Despite targeting cellwall polymers, the crude multi-component enzyme mixture containing pectinase,
hemicellulase, and cellulase (amounts decreasing in order) did not compromise the host
receptor enough to prevent virus attachment as evident by a productive virus infection.
The host receptor, which is likely a carbohydrate [81], is uniformly present over the
entire surface of the alga. Once inside the cell, deposited viral DNA could be recognized
by the GT gene-targeting RNPs. However, this doesn’t explain why SiC and
electroporation procedures were unsuccessful in obtaining mutant viruses given evidence
of RNP delivery inside NC64A was greater using these delivery techniques compared to
macerozyme-treated cells (Figure 2.4c and Figure 2.4d). Perhaps the fluorescently
labeled cells, although in greater quantity, were either dead or compromised in health that
prevented the desired viral DNA editing.
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2.4. SILICON CARBIDE WHISKERS
2.4.A. Introduction
We were interested in developing a simple, inexpensive technique for introducing
DNA into walled algal cells. In 1990, Kaeppler [189] reported using SiC whiskers to
mediate the introduction of DNA into plant cells. We adopted a technique based on the
SiC method of Kaeppler that uses SiC whiskers to transform the microalgae C.
reinhardtii with its intact cell wall [190]. This SiC method reported transformants at an
efficiency of up to 10−5 per cell for walled cells and up to 10−4 per cell for cw-15 strains
(protoplast). In contrast to agitation of the cells with glass beads, agitating the cells with
SiC whiskers for up to 10 min resulted in little loss in cell viability. The gentle nature of
the SiC protocol may allow more flexibility in the development of protocols for the
transformation of Chlorella strains.
The SiC whiskers method involves the mixing (e.g., by vortex treatment) of cells
in liquid medium with whiskers and exogenous DNA and/or protein. The resulting
collisions between cells and whiskers appear to lead to cell penetration and DNA delivery
[191]. Here, we aimed to utilize FACS again to evaluate the delivery of fluorescently
labeled CRISPR-targeting cargo inside NC64A using the SiC whiskers method.
2.4.B. Materials and Methods
NC64A transfection by SiC whiskers. For each transformation, cells were mixed with
sterile SiC whiskers and preassembled Cas9 protein-sgRNA RNP +/- ssODNs armed
with the protospacer sequence targeting domain 1 of CA-4B 034r. Samples were agitated
by a vortex mixer at top speed for 2 min, stopping briefly every 10 s. Immediately after
vortexing, samples were diluted with PEG and infected with CA-4B. Following overnight
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infection, virus mutants were selected using the same antibody selection assay previously
described. Virus plaques were analyzed by PCR and sequenced to detect Indel mutations
by NHEJ, while 034r amplicons were also incubated with MscI to screen for ssODNmediated HDR.
2.4.C. Results and Discussion
FACS analysis of the SiC whiskers treated NC64A cells showed between 10-20%
cell fluorescence (Figure 2.4c) suggesting positive delivery of the RNPs inside the alga
cells. We speculate that cell wall perforations allowed RNP complexes brief access inside
the cell. Immediately following electroporation, cells were infected with CA-4B. In
theory, once viral DNA was deposited inside the alga cell, the naked nucleic acid would
be available for RNP-binding and subsequent 034r cleavage. The edited viral DNA
would be subsequently replicated and packaged. Following antibody selection, we
expected to recover an NHEJ indel event in CA-4B at the RNP-designated target site,
however, we were unsuccessful. Although virus plaques were recovered, sequencing
results confirmed the wildtype 034r was intact. Given these sequencing results, these
plaques were likely caused by escape viruses that evaded wildtype antibody binding.
2.5. ELECTROPORATION
2.5.A. Introduction
Electroporation is widely used for transformation of competent and noncompetent bacteria, yeast, mammalian and microalgae cells [192]. This technique
involves the use of high-intensity electric pulses to induce the permeabilization of the cell
membrane, thus allowing the uptake of DNA directly from the surrounding environment.
The effectiveness of transformation through this method is mediated by length of the
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electric pulses, the composition of the medium, presence or absence of a cell wall,
concentration of the heterogeneous DNA and strength of the electric field. The medium
often demonstrates an increase in temperature after the procedure and as a result, a
portion of the cells present in the suspension will be lost. Electroporation has already
been successfully used for the transformation of many microalgae species such as C.
reinhardtii, Nannochloropsis sp., Dunaliella sp., and some Chlorella sp. not including
NC64A [145].
Transformation of Chlorella cells via the method of electroporation alone must be
performed under extreme conditions (high voltage and long pulse) that can cause damage
to cells, affecting their ability to function normally. Even under such extreme conditions,
mostly transient transgene expression has been achieved [193]. Widely used in bacteria, it
can be used for microalgae that have a weakened cell wall [194]. In the microalgae, C.
ellipsoidea and C. reinhardtii, mutant strains without cell walls are easy to transform
[135, 146], suggesting that other Chlorella species such as NC64A can have the same
transformation potential if the physical barrier of the cell wall is eliminated. The
thickness of the cell wall of the free-living C. variabilis is between 11–17 nm and that of
the symbiotic C. variabilis is 6–10 nm [195]. A major wall component is chitin, a
glucosamine polymer not normally present in green algae likely contributes to the cell’s
impermeability. The total makeup of the NC64A cell wall isn’t completely known,
however Glc is the main structural component [186], and therefore, its dilution or
elimination by use of digestive enzymes prior to electroporation could be a crucial step
for reliable transformation.
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2.5.B. Materials and Methods
NC64A transfection by electroporation. Purified Cas9 (100 μg) was preincubated at a
1:3 molar ratio with three 034r-targeting sgRNAs at 37 °C for 15 min to form RNP
complexes. For transfection, 250 μL cell culture (2.5 × 108 cells/mL) supplemented with
sucrose (40 mM) were mixed with preincubated RNPs, and ssODNs. Cells were
electroporated in 2-mm cuvettes (600 V, 50 μF, 200 Ω) by using Gene Pulser Xcell
(Biorad). Immediately after electroporation, 800 μL of MBBM with 40 mM sucrose was
added to the sample and the cells were infected with CA-4B (MOI 5). Following
overnight infection, virus mutants were selected using the same antibody selection assay
previously described. Virus plaques were analyzed by PCR and sequenced to detect Indel
mutations by NHEJ, while 034r amplicons were also incubated with MscI to screen for
ssODN-mediated HDR.
2.5.C. Results and Discussion
FACS analysis of the electroporated NC64A cells showed the highest cell
fluorescence of all delivery methods (approximately 20%) suggesting positive delivery of
the RNPs inside the alga cells (Figure 2.4d). We speculate that electroporation-induced
cell wall perforations allowed RNP complexes brief access inside the cell. Immediately
following electroporation, cells were infected with CA-4B. In theory, once viral DNA
was deposited inside the alga cell, the naked nucleic acid would be available for RNPbinding and subsequent 034r cleavage. The edited viral DNA would be subsequently
replicated and packaged. Following antibody selection, we expected to recover an NHEJ
indel event in CA-4B at the RNP-designated target site, however, we were unsuccessful.
Although virus plaques were recovered, sequencing results confirmed the wildtype 034r
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was intact. Given these sequencing results, these plaques were likely caused by escape
viruses that evaded wildtype antibody binding.
2.6. CELL-PENETRATING PEPTIDES
2.6.A. Introduction
CPPs are short peptides that facilitate cellular intake and uptake of molecules.
This group of short peptides with at most 30 to 35 amino acid residues, has the ability to
translocate across the cell membrane [196]. In animal system, the direct protein delivery
strategy using CPPs has been extensively developed [197-199]. However, the peptidemediated protein delivery system in plants and algae are still scarcely developed. CPPs
are of different sizes, amino acid sequences, and charges but all CPPs have one distinct
characteristic, which is the ability to translocate the plasma membrane and facilitate the
delivery of various molecular cargoes to the cytoplasm or an organelle; thus, they act as
molecular delivery vehicles. There has been no real consensus as to the mechanism of
CPP translocation, but the theories of CPP translocation can be classified into three main
entry mechanisms: direct penetration in the membrane, endocytosis-mediated entry, and
translocation through the formation of a transitory structure.
Previous studies demonstrated that CPP-fused to a polycationic peptide (an
alternate copolymer of lysine and histidine, (KH)9), which was termed as fusion peptides,
is a more efficient nucleic acid carrier compared with that of the CPP alone in intact
plants [200]. By using the fusion peptides, the negatively charged cargo preferentially
interacts with the polycationic peptide through ionic interactions, whereas the CPP
interacts with fewer cargo molecules and is preferentially present on the surface of
peptide-cargo complexes. The higher number of CPPs at the surface of the complexes
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leads to a higher efficiency in gene delivery [201]. Based on the concept of fusion
peptide, two protein delivery carriers, (BP100)2K8 and BP100(KH)9, were designed by
fusing a CPP, i.e., BP100 or BP100 dimer, and a polycationic peptide, i.e., alternate
copolymer of lysine and histidine, (KH)9 or eight consecutive lysine residues, K8. The
polylysine is known to destabilize cell-membrane via electrostatic interaction between the
protonated amine and the negatively charged cell membrane [202]. On the other hand, the
copolymer of lysine and histidine has the ability to promote the buffering effect on the
prelysomal vesicle [203]. In this current study, we assumed that the polycationic peptides
[(KH)9 and K8] also play an important role in the electrostatic interaction with negatively
charged protein cargo, similarly to the ionic interaction with plasmid DNA as described
in previous studies [200, 204].
2.6.B. Materials and Methods
Peptides. Peptides were gifted by Dr. Heriberto Cerutti (UNL): (BP100)2K8
(KKLFKKILKYLKKLFKKILKYLKKKKKKKK, theoretical pI/Mw: 10.75/3851.13 Da)
and BP100(KH)9 (KKLFKKILKYLKHKHKHKHKHKHKHKHKH, theoretical pI/Mw:
10.81/ 3809.71 Da).
Complex formation. Peptide/RNP complexes were prepared by adding different
amounts of each peptide to RNP at various ratios (0.1, 0.5, 1, 2, 5, 10, and 20). The
solution was thoroughly mixed by repeated pipetting and allowed to stabilize for 30 min
at 25 °C.
NC64A transfection by CPPs. Referring to a previous study [173], 10 μg of Cas9 and
12 μg of sgRNA were incubated at room temperature for 15 min. A prepared cell sample
of 100 μl at 3 × 108 cells/mL was added to the incubated RNP, ssODNs, and gently
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mixed. Tested independently, (BP100)2K8 or BP100(KH)9 was added to the sample and
mixed immediately. In a series of experiments, we observed that there was no significant
difference between the two types of treatment with CPPs: (1) pre-incubation of RNP and
CPP for the formation of complex, and (2) treatment of CPP and RNP to the cell
simultaneously. After incubation of the cells mixed with the RNP and CPP for 30 min at
25 °C, trypsin was added, and the mixture was incubated for 15 min at 37 °C. The sample
was washed by MBBM media and transferred to 10 mL of MBBM media and incubated
for 16 h under dim light without shaking as a “recovery” step. Following incubation, cells
were infected with CA-4B (MOI 5) and incubated overnight (24 h). Following overnight
infection, virus mutants were selected using the same antibody selection assay previously
described. Virus plaques were analyzed by PCR and sequenced to detect Indel mutations
by NHEJ, while 034r amplicons were also incubated with MscI to screen for ssODNmediated HDR.
2.6.C. Results and Discussion
We examined the effect of parameters, such as the peptide/RNP ratio and serum
addition, on peptide-mediated transfection. Properties of peptides (DNA binding stability
and condensation capacity) and of peptide/RNP complexes (size and surface charge)
were investigated because these are known to vary as a function of the peptide/RNP ratio.
Following antibody selection, we expected to recover an NHEJ indel event in CA-4B at
the RNP-designated target site. However, we were unsuccessful. Although virus plaques
were recovered, sequencing results confirmed the wildtype 034r was intact. Given these
sequencing results, these plaques were likely caused by escape viruses that evaded
wildtype antibody binding.
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2.7. AGROBACTERIUM-MEDIATED
2.7.A. Introduction
Agrobacterium tumefaciens is a gram-negative bacterium species found in soil,
more commonly known for infecting a wide variety of dicotyledonous plants, causing the
growth of tumors on their stems near the surface of the soil (a disease referred to as
crown gall disease). The infection is triggered by the release of phenolic compounds from
wounds in plant roots and is controlled by the “vir regulon” present in the Ti plasmid.
This leads to the transfer of the T-DNA from the bacterium’s Ti plasmid (tumor inducing
plasmid) into the plant cells where it permanently integrates into the host genome causing
the aforementioned tumors [133]. It was later discovered that disarmed Ti plasmids could
be used to deliver foreign DNA into plant cells in order to produce genetically engineered
plants with improved features [205].
More recently it was demonstrated that this same system could also be used to
transform microalgae [133]. This technique holds several advantages over other
transformation methods. Not only does it allow the transfer of large DNA molecules with
little rearrangements, but also demonstrates a high rate of integration into potentially
transcribed regions and usually leads to the integration of a singular transgene in the
target’s genome [141]. In contrast with other transformation procedures, transformation
frequency and gene stability do not appear to be frequent complications and can also
result in homologous recombination facilitating the localization of the integrated DNA
segments. Agrobacterium tumefaciens-mediated transformation is a form of conjugation
as it also involves the physical contact between the organisms involved in the process.
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Kumar et al. (2004) [147] were able to implement this method for the first time in
an algal system through the nuclear transformation of C. reinhardtii. When compared
with other approaches like the glass bead method, transformation mediated by
Agrobacterium was shown to have an increase in transformation frequency of 50-fold
when transforming C. reinhardtii. In addition, it allows for the nuclear transformation of
microalgae without the need for the removal of the cell wall, a trait only shared with
particle bombardment.
These aforementioned alga transformation protocols except particle bombardment
often utilize cell wall less strains or require an enzymatic step to facilitate the removal of
the cell wall prior to transformation. In light of these stepwise procedures, we were
interested in the development of a transformation system that doesn’t require alga cell
wall treatment. Here, we transferred T-DNA of A. tumefaciens strain LBA4404 harboring
the binary vector pCAMBIA1304 containing the gfp:gusA fusion reporter, a hygromycin
phosphotransferase (hpt) selectable marker driven by the CaMV35S promoter, and the
transgene a064r-D1 from PBCV-1 antigenic mutant EPA-1. NC64A Transformation was
assessed by monitoring transient β-glucuronidase (GUS) and gfp expression 2 days p.i. In
theory, if NC64A transformation is achieved, the hygromycin-resistant recombinant alga
expressing the truncated form of A064R (domain 1 only per nonsense mutation) would
produce some shortened EPA-1 glycans at the MCP surface of newly formed viruses
when infected with wild-type PBCV-1. In turn, these virus mutants would be subject to
antibody selection as described above.
2.7.B. Materials and Methods
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Agrobacterium strain and vectors. The binary vector pCAMBIA1303 containing a
gfp:gusA fusion reporter, domain 1 of gene a064r from a PBCV-1 antigenic mutant
referred to as EPA-1, and a selectable marker for hygromycin B resistance driven by the
CaMV 35S promoter were used for transformation. The binary vector was mobilized into
A. tumefaciens strain LBA4404 by using the Gene Pulser Xcell electroporator (Biorad)
according to manufacturer’s protocol. Transformed cells were aliquoted and maintained
at -80°C in 25% (v/v) glycerol.
Antibiotic sensitivity test. The sensitivity of A. tumefaciens towards the antibiotic
cefotaxime was tested by inoculating 200 L of Agrobacterium culture (OD600 = 1.0) in 5
mL LB broth supplemented with varying concentrations of cefotaxime (0, 50, 100, 150,
200, 300, 400 and 500 mg/L) and the growth of Agrobacterium in each concentration was
measured spectrophotometrically at OD600 after 2 days. The effect of the antibiotic
cefotaxime on the viability of NC64A was accessed by plating a serially-diluted
microalgae culture on solid MBBM supplemented with different concentrations of
cefotaxime (0, 100, 200, 300, 400 and 500 mg/L). The agar plates were incubated in the
dark for 2 days at 25 °C before exposure to light and the number of surviving colonies
from the dilution that produced less than 100 colonies was counted in duplicates after 2
weeks. In order to determine the minimum inhibitory concentration of hygromycin B, 1 x
106 NC64A cells were plated on solid MBBM medium supplemented with 500 mg/L
cefotaxime and varying concentrations of hygromycin B (6, 8, 10, 12, 14, 16, 18, 20, 23
and 26 mg/L) and each treatment was tested in triplicates. The agar plates were incubated
for 2 days in the dark at 25 °C before exposure to light and the number of surviving
colonies was accessed after 20 days.
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NC64A transfection by Agrobacterium. A general transformation procedure for NC64A
was established based on work done by Kumar et al. (2004) [133] on transformation of
C. reinhardtii with some adjustment as described here. Single colonies of Agrobacterium
initiated from a frozen stock were used to inoculate 10 mL of LB supplemented with 5
mM Glc, 100 mg/L streptomycin and 50 mg/L kanamycin and grown overnight in a
rotary shaker at 27 °C with shaking at 200 rpm in the dark. Five mL of this overnight
culture was used to inoculate 50 mL of the same medium and it was grown in the dark at
27 °C with shaking at 200 rpm until OD600 = 0.8–1.2. The bacterial culture was harvested
by centrifugation and washed once with induction medium (MBBM plus 150 M
acetosyringone, pH 5.6) and diluted to a final density of OD600 = 0.5. Prior to cocultivation, a total of 5 x 106 NC64A cells from a log-phase culture (OD600 = 0.5–1.0)
were pre-cultured for 5 days on MBBM agarose plates at 25 °C and harvested with
induction medium on the day of co-cultivation. The algal cell pellet was mixed with 200
L of the bacterial suspension and plated on induction medium solidified with 1.2%
(w/v) bacto-agar. Co-cultivation was performed for 3 days at 25 °C in the dark.
Following co-cultivation, cells were harvested with MBBM supplemented with 500 mg/L
cefotaxime in a total volume of 7 mL and incubated in the dark at 25 °C for 2 days to
eliminate Agrobacterium. Visualization of gfp expression was performed using a
confocal fluorescent microscope (Nikon A1R-Ti2 confocal system, UNL Microscopy
Core). Subsequently, the remaining cells were plated on selective media containing 20
mg/L hygromycin B and 500 mg/L cefotaxime and incubated at 25 °C in the dark for 2
days before exposure to light. Resistant colonies were propagated on non-selective media
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and utilized for PCR analysis. Detection of contaminating Agrobacterium was performed
by growing cells on LB agar plates for at least 7 days at 25 °C in the dark.
2.7.C. Results and Discussion
A. tumefaciens was suppressed at a cefotaxime concentration as low as 50 mg/L
(Figure 2.5a) whereas the growth of NC64A was found to be uninhibited in cefotaximesupplemented media up to 500 mg/L (Figure 2.5b). Thus, the highest concentration (500
mg/L) of cefotaxime was selected for all experiments to ensure thorough elimination of
Agrobacterium post-transformation. The lowest concentration of hygromycin B which
completely inhibited the growth of NC64A was 20 mg/L (Figure 2.5c), and this
concentration was used for subsequent selection of transformants.
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Figure 2.5. The effects of antibiotics on Agrobacterium and NC64A. (a) The effect of
cefotaxime on Agrobacterium viability. The effect of (b) cefotaxime and (c) hygromycin
on NC64A viability.
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Colony PCR of Agrobacterium colonies post electroporation with the
recombinant pCAMBIA1303 validated the binary vector was successfully mobilized
LBA4404 (Figure 2.6a). A total of eight putative hygromycin-resistant single colonies
that appeared within 20 days on selection media (containing 20 mg/L hygromycin and
500 mg/L cefotaxime) were randomly selected and grown in liquid media (containing
500 mg/L cefotaxime but lacking hygromycin) before the DNA was extracted and used in
PCR analysis. Amplification with EPA-1 a064r domain 1 gene-specific primers
successfully detected the 633 bp a064r gene fragment (25 kDa) from seven putative
transgenic lines (Figure 2.6a), which represents 87.5% of the total number of screened
colonies. To rule out Agrobacterium contamination, amplification with KanR genespecific primers only produced the expected 795 KanR gene in LBA4404 (positive
control) but not in the seven putative NC64A transgenic lines (Figure 2.6b). The presence
and absence of these gene-specific fragments in seven putative transgenic lines with no
amplification product detected in non-infected wild-type NC64A indicated the successful
transfer of both the hygromycin marker and the GFP-GUS reporter gene as a single TDNA unit flanked by the left and right borders.
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Figure 2.6. PCR analysis of putative NC64A transformants transformed with
recombinant pCAMBIA1303 a064r domain 1. (a) Amplification of the 633 bp
fragment of the a064r domain 1 gene fragment from four LBA4404 colonies postelectroporation, and eight NC64A colonies after agro-mediation transfection. (b)
Amplification of the KanR gene from LBA4404 (positive control) but not in the seven
putative NC64A transgenic lines. (c) Transgenic NC64A colonies on selective media
(containing 20 mg/L hygromycin and 500 mg/L cefotaxime).

The identity of the PCR amplicons derived from transgenic NC64A colonies
(Figure 2.6c) were further confirmed to be positive by DNA sequencing where sequence
alignment showed 99 and 98% identity to the hpt and gfp-gusA genes in pCAMBIA1303
respectively (Gene Bank accession no. AF234300). Visualization of GFP using a
fluorescent microscope confirmed weak expression of the gfp gene in transformed cells
as bright green fluorescence (Figure 2.7). The failure of many hygromycin-resistant
colonies to produce any amplification product for either primer pair indicates the
incidence of ‘escapes’ through antibiotic selection. The seven transgenic NC64A lines
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that were previously confirmed positive for a064r domain 1 by PCR could not be
maintained or subcultured on hygromycin-supplemented media. No GUS-positive cell
was detected in transgenic lines post-selection with hygromycin, although PCR
amplification confirmed the presence of the gfp-gusA genes (data not shown). This may
indicate the possibility of the gfp-gusA genes silencing in transgenic lines.

Figure 2.7. Transformation of NC64A with pCAMBIA1304 vector carrying the gfp–
gusA fusion reporter genes. Confocal fluorescent microscopy of live NC64A cells
transformed with pCAMBIA1304 by Agrobacterium tumefaciens imaged with green, red,
and GFP channels (from left to right). The GFP florescent channels shows the appearance
of gfp expression. Bar represents approximately 5 m.

In summary, a potentially simple method for Agrobacterium-mediated
transformation of Chlorella variabilis NC64A was developed. Seven PCR-positive
transformants were obtained, and the presence of the viral gene fragment suggests that
the T-DNA was integrated into the genome; however, more extensive studies are needed
to elucidate possible factors and mechanisms contributing to the loss of the gusA-gfp
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expression. Other vector systems and/or promoters might also need to be tested on this
microalga to develop a better transformation system. Nonetheless, the finding opens the
possibility of further genetic manipulation of this commercially important microalga with
other genes of interest.
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CHAPTER III
PBCV-1 PROTEINS A064R AND A061L TOGETHER HAVE FOUR
TRANSFERASE ACTIVITIES INVOLVED IN GLYCAN SYNTHESIS
3.1. OVERVIEW
PBCV-1 encodes seven putative sugar manipulating enzymes with most of them
predicted to be involved in the synthesis of its N-glycan(s) as disclosed by bioinformatic
analyses [97, 111]: A064R (638 amino acids), A111/114R (860 aa), A219/222/226R (677
aa), A473L (517 aa), A546L (396 aa), A071R (354 aa), and A075L (280 aa). However,
this number is less than the 10 sugars present in the N-glycan attached to the MCP.
Several possibilities could explain this discrepancy: 1) One or more of the seven putative
GTases might have multiple functional domains, making this restricted repertoire of
enzymes sufficient to synthesize these structures; 2) PBCV-1 genes encode enzymes that
do not resemble GTases in the databases and, hence, they are not recognized during query
searches; 3) a host-encoded GT(s) could contribute to the glycosylation process.
Among the genes mentioned above, the protein coded by gene a064r is of interest
because it is found in PBCV-1 but not in other chloroviruses where the glycan structures
are known [51, 107, 206]. Also, experimental evidence shows that isolated spontaneous
mutants (or antigenic variants) of PBCV-1 with mutations in a064r have truncated glycan
structures [111, 113]. A combination of genetic and structural analyses suggested that the
A064R protein has three putative domains of ∼200 amino acids each (SI Appendix, Fig.
S1 [175]). Domain 1 (A064R-D1) was predicted to encode a β- L-rhamnosyltransferase
and domain 3 (A064R-D3) was predicted to encode a S-adenosyl-L-methionine-
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dependent MT (SAM)-dependent MT that decorates two positions in the terminal α-LRha unit [111]. The A064R domain 2 (A064R-D2) was hypothesized to encode an α-Lrhamnosyltransferase, despite only resembling bacterial proteins with unknown functions,
thus, suggesting that it could be a new GT family.
Here we provide evidence that the predictions about the three A064R domains are
correct with the exception of A064R-D3, which adds only one methyl group and not two
as proposed. It methylates O-2 of the α-L-Rha residue, while O-3 methylation is
accomplished by another virus-encoded protein A061L.
3.2. GLYCOSYLTRANSFERASE A064R AND METHYLTRANSFERASE A061L
The chloroviruses are unusual because they are predicted to encode most, if not
all, of the machinery to synthesize the glycans attached to their MCP. Here we show that
two of the virus-encoded proteins A064R and A061L are functionally active. A064R has
three domains: The first two are GTases and the third domain is a MT. A061L has a MT
activity. The action of these two enzymes produce the fragment 2,3-di-O-methyl-α-LRha-(1→2)-β-L-Rha, which is part of the complex N-linked glycan attached to the virus
capsid protein. A064R domain 2 is a member of a new GT family. This provides direct
evidence that the synthesis of PBCV-1 glycans are accomplished with virus-encoded
enzymes.
3.2.A. Materials and Methods
Recombinant proteins. All recombinant proteins were expressed in E. coli cells. The
A064R full-length protein was produced with a C-terminal 6xHis-tag (SI Appendix, Fig.
S1 A and B [175]) using the pET23a vector as described [207]. Protein purification to
homogeneity was performed using the Probond nickel-chelating resin (ThermoFisher,
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code R801-01), following the manufacturer’s protocol. A064R domains (SI Appendix,
Fig. S1 A and B [175]) were cloned and expressed in the pGEX-6P1 vector as described
[207] obtaining fusion proteins with the glutathione S-transferase (GST) tag at the N
terminus, that were purified using glutathione Sepharose 4B (GE Healthcare, code no.
17–0756-01). The glutathione-Sepharose-bound proteins were used for the enzymatic
reactions. Cleavage was achieved for A064R-D1 only by using Prescission protease (GE
Healthcare, code no. 27–0843-01) on the column, and the released protein was
concentrated using Amicon Ultra-4 (Millipore). The released domain was used for the
UDP-GloTM assay. Purity of full-length A064R-6xHis protein and of the GST-fusion
domains was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS/PAGE) and Coomassie blue staining (SI Appendix, Fig. S1C [175]). A061L protein
(SI Appendix, Fig. S1 [175]) was cloned and expressed in pGEX-5X-1 expression vector
(GE Healthcare), producing a GST tag at the N terminus of the target protein. The
recombinant protein was purified on glutathione Sepharose as before and used for
enzymatic reactions (more details in SI Appendix, Materials and Methods [175]). All
eluted proteins were resolved by SDS/PAGE with Coomassie brilliant blue staining
solution.
Enzymatic reactions. All of the reactions were performed at 25 °C in phosphate buffer
saline ([PBS]; Sigma-Aldrich, code no. P4417, composition: 0.01- M phosphate buffer,
0.0027-M potassium chloride, and 0.137-M sodium chloride, pH 7.4) by using the
enzyme still attached to the resin through its GST tag or it’s His tag in the case of the
whole A064R. In a typical experiment, the reaction volume was about 150 μL and
included 50 μL of resin (glutathione Sepharose 4B GE Healthcare or Probond nickel-
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chelating resin) with ∼250 μg of protein adsorbed unless otherwise specified. All
enzymatic reactions were screened via high-pressure liquid chromatography (HPLC),
using a C18 column (Phenomenex Kinetex 5 μ, 2,50 × 4.60 mm, code no. 00G-4601-E0)
and 70% methanol as an eluent (flow rate at 0.8 mL/min) by injecting 10 μL of the crude
reaction after centrifugation. For A064R-D1, the reaction was performed by using
oligosaccharide 1 (1.5 mM) (Figure 3.1) as an acceptor and UDP-β-L-Rha (1.5 mM) as a
donor in the presence of Mn2+ (2 mM). In order to verify the cation dependence of the
enzyme, the reaction was repeated by adding EDTA (1 mM) to the protein 30 min prior
to the addition of all of the other reagents except the cation. For A064R-D2, three
different constructs were produced and tested: D2 (191–405 aa), D2L (191–438 aa), and
D2L2 (213–438 aa). All three constructs were tested with oligosaccharide 2 (1.5 mM) as
an acceptor and UDP-β-L-Rha (1.5 mM) and with or without cations (Mg2+ and Mn2+, 2
mM). To exclude any cation dependency, a reaction with D2L was also tested by adding
EDTA (0.5 mM), keeping the other reagents unchanged. The D2L reaction was repeated
replacing acceptor oligosaccharide 2 with the L-Rha monosaccharide (1.5 mM). The resin
with A064R-D1D2 was suspended in PBS buffer and incubated with oligosaccharide 1
(1.5-mM), UDP-β-L-Rha (3.6 mM) and Mn2+ (2 mM). In the second reaction,
oligosaccharide 6 (1.5 mM) was used instead of oligosaccharide 1, while all other
components were kept unchanged. The resin with the full-length A064R attached was
suspended with oligosaccharide 1 (1.5 mM), UDP-β-L-Rha (3.4 mM), the precursor for
the MTs SAM (CAS no. 86867–01-8; code no. A7007, Microtech), and with both Mn2+
and Mg2+ (2 mM each). As for A061L, two reactions were performed by varying the
nature of the acceptor. In the first reaction, oligosaccharide 3 (1 mM) was used as an
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acceptor along with an excess of SAM (ca. 2 mM), Mn2+ and Mg2+ (2 mM each); in the
second reaction, oligosaccharide 3 was replaced with oligosaccharide 4.

Figure 3.1. (600 MHz and 310 K, D2O) 1H NMR spectra detailing the anomeric
region of the oligosaccharides 1–7, drawn as a cartoon next to each spectrum. Each
monosaccharide unit is labeled with a capital letter, and the full NMR attribution of each
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compound is reported in the SI Appendix [175]. The peak at ca. 4.7 ppm is the residual
solvent signal.

Compounds isolation. The crude reaction solutions were centrifuged using spin columns
with collection tubes (code no. H6787, Sigma-Aldrich) to remove the resin, and then, the
pure products were recovered by C18 Sep-Pak cartridges (pore size 125 Å, particle size
55–105 μm, code no. WAT051910, Waters) as detailed below. The Sep-Pak cartridge
was activated with 10 mL of ethanol, 4 mL of acetonitrile, and 10 mL of water. After
being loaded with the supernatant, the following elution was performed: 20 mL of water,
15 mL of acetonitrile/water 1:4, 5 mL of acetonitrile, and 20 mL of ethanol. All fractions
were dried and analyzed via NMR spectroscopy.
Bioluminescent assay: UDP-GloTM assay. Two UDP standard curves were prepared in a
96-well plate, performing a serial twofold dilution as described in the UDP-GloTM kit
(code no. V6961, Promega), obtaining 12 solutions at different UDP concentrations. One
reaction contained Mn2+ the other contained Mg2+ at the same concentration (40 mM).
Thereafter, 25 μL of each solution was transferred to a second 96-well plate, and 25 μL
of UDP detection reagent (provided by the UDP-GloTM kit) was added; the solutions
were incubated at 25 °C for 1 h, and luminescence was measured with a luminometer.
Reactions that involved the A064R-D1 enzyme, oligosaccharide 1 as an acceptor and
UDP- β-L-Rha as a donor in separate phosphate buffer solutions (one with Mg2+ and the
other with Mn2+), were performed maintaining a constant ratio of UDP-L-Rha/1 (2:1
ratio; 2.470 and 1.250 nmol, respectively), while the GT amount decreased from the first
solutions to the last where GT was absent. Similar to the UDP standard curves, the
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solutions at different GT concentrations were obtained using twofold serial dilutions: 100
μL of the GT solution (5 μL of GT 150 μg/mL; 5 μL Mn2+/or Mg2+, 40 mM; 4.75 μL PBS
20×; 85.25 μL of water) was added in the first well followed by the addition of 50 μL
buffer (composed of Mn2+/ Mg2+, 40 mM; PBS 20×, and H2O) to the additional 11 wells.
Then, 15 μL from each well was transferred into 12 wells of another 96-well plate, and
10 μL of the solution containing UDP-L-Rha (3.3 mM) and oligosaccharide 1 (1 mM)
was added. The reactions were incubated at 25 °C for 1 h, after that 25 μL of the UDPdetection buffer was added to each well, and the solutions were kept at the same
temperature for one additional hour prior to measuring luminescence. Two replicas for
each experiment were performed. The same strategy was used for the following two
reactions, in which the activated sugar donor or the acceptor substrate were changed,
maintaining the 2:1 ratio as before: in one, the UDP-L-Rha was substituted with the UDPD-Glc (10

mM), and in the other, the D-Xyl monosaccharide (1 mM) was used instead of

oligosaccharide 1. Experiments were performed in the presence of both bivalent cations.
Luminescence measurements were performed with a Synergy HT multimode microplate
reader (BioTek instrument) using a 96-well microplate with standard 128 × 86-mm
geometry with an integration time of 1.0 s. Luminescence was measured by a low-noise
photomultiplier detector through an empty filter position in the emission filter wheel.
Data analysis and the construction of the graphs were achieved with Excel Software.
NMR spectroscopy. All NMR experiments of the oligosaccharides from 1 to 7 in Figure
2 were recorded in D2O at 310 K on a Bruker DRX-600 MHz (1H: 600-MHz and 13C:
150-MHz) instrument equipped with a cryoprobe except for the Rha disaccharide for
which a temperature of 298 K was used. All chemical shifts are referred to internal
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acetone (1H 2.225 and 13C 31.45 ppm). The set of 2D spectra (correlation spectroscopy,
TOCSY, T-ROESY, and HSQC) were measured for each substrate, except for
oligosaccharides 3, 7, and the α-L-Rha-(1→2)-L-Rha disaccharide for which only the
heteronuclear single quantum correlation (HSQC) and the total correlation spectroscopy
(TOCSY) experiments were acquired and for structures 1 and 2 where HMBC was also
recorded. Homonuclear experiments were recorded using 512 free induction decays
(FIDs) of 2,048 complex data points, setting 24 scans per FID for all experiments,
whereas for structures 3 and 4, 32 scans per FID were set in order to obtain a better signal
to noise ratio. Mixing time of 100 ms was applied for TOCSY and 300 ms for T-ROESY
spectra acquisitions. 1H-13C heteronuclear experiments were acquired with 512 FIDs of
2,048 complex points with 40–80 scans per FID, depending on the sample abundance.
Standard Bruker software Topspin 3.1 was used to process and analyze all spectra. NMR
operating conditions used for the characterization of the synthetic intermediates of
oligosaccharides 1 and 6 are reported in the SI Appendix [175].
Phylogenetic analyses. Multiple sequence alignment and phylogenetic reconstructions
were performed using the Environment for Tree Exploration3 (ETE3) v3.1.1 program
[208] as implemented on the GenomeNet (https://www. genome.jp/tools/ete/).
Phylogenetic trees were constructed using maximum likelihood and neighbor-joining
approaches using PhyML v20160115 ran with model pa- rameters: -f m–pinv e -o tlr–
nclasses 4–bootstrap 100–alpha e [209]. The branch supports are the χ2-based parametric
values return by the approximate likelihood ratio test. Maximum-likelihood annotation
was generated by Interactive Tree of Life (iTOL) [210]. Viral proteins were used as
queries to search the publicly available NCBI nonredundant sequence database using
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BLASTp and hits filtered based on general parameters excluding chloroviruses. The
characterized GT domains were identified using UniProt [211] and HHpred [212] from
selected rhamnosyltransferases in the CAZy database.
Protein modeling. PBCV-1 A064R-D3 and A061L structure predictions were
constructed by Phyre2 [213]. Molecular docking of viral proteins complexed with SAM
were performed using PatchDock [214], an algorithm based on shape complementarity
principles. Protein complexes were inputted into the molecular modeling system,
Chimera where 3D protein models were con- structed. SAM-binding residues were
generated by SAMbinder [215, 216]. Final drawings and residue analysis were prepared
with molecular graphics system PyMol, a molecular graphics system, Version 1.2r3pre,
Schrödinger, LLC.
Data availability. All study data are included in the article and supporting information
and the UniProt Knowledgebase (UniProtKB), https://www. uniprot.org/ (accession no.
A0A516L7Y9).
3.2.B. Results and Discussion
A064R-D1: β-L-Rhamnosyltransferase activity. A064R-D1, amino acid residues 1–212
in the PBCV-1 A064R protein (SI Appendix, Fig. S1A [175]) was originally predicted to
be a GT in subfamily 34 (GT34; retaining) [217]. Thereafter, A064R-D1 was expressed
as a recombinant protein and crystallized confirming it to be a member of the GT34
subfamily and preferring uridine 5′-diphosphate (UDP)-Glc as a donor substrate.
However, this study occurred before the PBCV-1 glycan structure(s) was known, and this
first hypothesis was later refuted by Speciale et al. [111] who predicted that A064R-D1
added L-Rha to D-Xyl.
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Here, we biochemically evaluated this prediction by using the tetrasaccharide 1
(Figure 3.1) as the acceptor substrate. This oligosaccharide is a simplified truncated
version of the N-glycan from PBCV-1 in which the D-Xyl is available for glycan
elongation. In contrast to the natural glycan, the Fuc in 1 is capped at the reducing end
with an octyl group (Figure 3.1 and SI Appendix, NMR Characterization, Figs. S2 and
S3, and Table S1 [175]), facilitating the monitoring of the reaction via HPLC and the
purification of the products. UDP- β-L-Rha was used as the donor, and the reaction was
monitored by either the HPLC or by the UDP-GloTM assay. When the reaction mixture
included Mn2+, the HPLC profile (Figure 3.2) showed the formation of pentasaccharide 2
while oligosaccharide 1 simultaneously decreased. NMR analysis of oligosaccharide 2
revealed an additional signal at 4.79 parts per million (ppm), labeled E, in the anomeric
region (Figure 3.1). Comparison of the HSQC spectrum of oligosaccharide 2 (SI
Appendix, Fig. S4 [175]) with that of oligosaccharide 1 identified the three common
residues: namely, A (2,3,4-substitued α-L-Fuc), B (terminal α-D-Gal), and C (terminal αD-Rha).

The β-D-Xyl unit (D) showed some chemical shift variations because of

glycosylation at O-4 as inferred by the downfield displacement of the corresponding
carbon chemical shift (79.4 ppm, SI Appendix, Table S2 [175]) compared to the
reference (70.7 ppm as found in 1, SI Appendix, Table S1 [175]).
As expected, the newly added residue in oligosaccharide 2 was a β-L-Rha (E)
linked at position 4 of D-Xyl (D) as proven by the diagnostic correlations found in both
heteronuclear multiple bond correlation (HMBC) and T-ROESY spectra (SI Appendix,
Figs. S4 and S5B [175]). The β-configuration of this anomeric center was inferred by the
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diagnostic nuclear Overhauser effect (NOE) contacts between the anomeric proton H-1 of
E with its H-3 and H-5 protons and confirmed by the 1JC,H value (160.3 Hz).
To demonstrate the importance of the cation, the same reaction was repeated
without Mn2+ along with EDTA; the HPLC profile (SI Appendix and Fig. 3B [175])
revealed that the enzyme required Mn2+ to function. Together, these results establish that
A064R-D1 acts as a Mn2+-dependent β-L-rhamnosyltransferase, able to form the β-LRha-(1→4)-β-D-Xyl linkage. Moreover, the complete conversion of the substrate attests
to a lack of a relevant hydrolytic activity versus the donor under the conditions tested,
similar to what is observed for the other enzymes (A064R-D2 and A064R-D1D2).
These results were confirmed by the bioluminescent UDP-GloTM assay in which
the specificity of the enzyme for Mn2+ and Mg2+ was tested, disclosing the enzyme’s
affinity for Mn2+ (SI Appendix, Fig. S6A [175]), in agreement with previous studies
[217]. The nature of the acceptor and donor substrates was also investigated, leading to
further information (SI Appendix, Fig. S6B [175]): 1) The enzyme did not recognize
UDP-α-D-Glc, in agreement with our previous prediction and contrary to previous studies
[217]; and 2) the enzyme recognized D-Xyl alone as an acceptor, albeit with a lower
affinity with respect to the oligosaccharide acceptor 1.

104

Figure 3.2. A064R-D1 demonstrates β-L-Rhamnosyltransferase activity. HPLC
chromatographic profiles obtained from the reaction of the A064R-D1 enzyme
(schematic at the bottom indicating its length in aa) with tetrasaccharide 1 (acceptor) and
UDP-β-L-Rha (donor) in the presence of (a) Mn2+ and (b) with EDTA and without
cations. Peak labels refer to oligosaccharide structures in Figure 3.1.
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A064R-D2: α-L-Rhamnosyltransferase activity. We previously predicted that A064RD2 adds the second L-Rha to the first L-Rha [97, 111]. To test this prediction, three
versions of the second domain were designed by changing the boundaries, cloned and
tested (SI Appendix, Fig. S1A [175]). The first construct (215 aa; named D2) was based
on bioinformatic studies. The other two constructs included 33 additional amino acids at
the C terminus and differed in length of the N-terminal region: D2L (aa 191–438) and
D2L2 (aa 213–438).
C-terminal elongation was investigated because the antigenic variant CME6 [111]
has a functional D2 domain longer than the bioinformatic prediction. The first 17 amino
acids of the N-terminal region were omitted in the D2L2 construct because they were
predicted to form a flexible loop and, therefore, unlikely required for activity. The three
proteins were screened for activity using pentasaccharide 2 (Figure 3.1) as an acceptor
and UDP-β-L-Rha as a donor with or without cations (Mg2+ or Mn2+). Interestingly, the
construct initially developed from the bioinformatic studies (D2) was not active (SI
Appendix, Fig. S7A [175]), while the other two D2L and D2L2 produced the
hexasaccharide 3 (SI Appendix, Fig. S7 B and C [175]).
The same reaction occurred with the D2L enzyme after five days of storage at 4
°C indicating that the enzyme was still active (SI Appendix, Fig. S7D [175]). 1H-NMR
spectroscopic investigation showed that oligosaccharide 3 had an additional anomeric
signal (5.03 ppm, labeled F) compared to 2 (Figure 3.1). Comparison of the HSQC
spectra of 2 and 3 (SI Appendix, Fig. S8A [175]) identified L-Fuc (A), D-Gal (B), α-DRha (C), and D-Xyl (D), while the chemical shifts of β-L-Rha (E′) were slightly different
due to its glycosylation at C-2, (78.1 ppm instead of 71.8 ppm, SI Appendix, Table S3
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[175]). The new unit F was a terminal α-L-Rha; its anomeric signal showed only one
correlation in the TOCSY pattern (SI Appendix, Fig. S8B [175]) ascribed to the H-1/H-2
cross peak, whereas the connections up to the methyl group H-6 (1.30 ppm) were visible
from H-2, while the C-5 chemical shift value at 69.7 ppm supported the α-configuration
of this residue [218].
These results establish that A064R-D2 is an inverting GT, that forms the α-L-Rha(1→2)-L-Rha linkage. Moreover, amino acids 191–212 at the N terminus do not
contribute to the functionality of the protein, but the 33 extra amino acids at the C
terminus in D2L2 and D2L are crucial for activity. It is possible that these residues are
involved in some dynamic interaction that enables the proper protein folding or confers
stability. The reaction was cation independent as confirmed by adding EDTA to the
mixture (SI Appendix, Fig. S7E [175]).
Two additional experiments were performed to learn more about the substrate
specificity of A064R-D2. First, the octyl xyloside 6 (Figure 3.1) was used as the acceptor
with the D2L construct, and no reaction occurred (SI Appendix, Fig. S7F [175]). Next,
the reaction was performed using L-Rha monosaccharide as the acceptor. In this case, the
reaction could not be monitored via HPLC, but NMR analysis after overnight incubation
revealed the formation of a α-L-Rha-(1→2)-L-Rha disaccharide. The 1H-NMR spectrum
of the product differed from those of the reagents Rha and UDP-Rha (SI Appendix, Fig.
S9A [175]), and the HSQC spectrum (SI Appendix, Fig. S9B [175]) displayed two
anomeric signals at 1H/13C 5.22/93.7 ppm and 4.96/103.3 ppm related to the two-linked
α-L-Rha at the reducing end (R) and to the terminal α-Rha (T), respectively (SI
Appendix, Table S4 [175]). The NMR analysis (SI Appendix, Fig. S9 B and C [175])

107
confirmed the identity of the disaccharide. In particular, the downfield shift of the C-2
carbon signal of residue R (to 80.3 ppm), confirmed its glycosylation and showed that the
enzyme was able to link α-L-Rha at O-2 to another L-Rha unit. A detailed inspection of
the spectra detected trace amounts of disaccharide α-L-Rha-(1→2)-β-L-Rha, as well.
Thus, D2L recognizes free Rha as an acceptor. Based on the structure of
oligosaccharide 2, which has a β-Rha, we hypothesize that the β-anomer of Rha is the
substrate of the enzyme not the α-anomer. Once formed, the reducing end of the
disaccharide is converted by mutarotation into the predominant α-form, while some of the
free α-Rha replaces the β-form that was consumed. This β-form then reacts with the
enzyme and additional UDP-β-L-Rha to give the disaccharide, and this process continues
up to the total consumption of the monosaccharide. This hypothesis needs to be validated
by future work. Because A064R-D2 resembles several proteins with unknown functions
in the GenBank, we predict that these homologs are likely to be undiscovered GTases.
Thus, A064R-D2 is a new cation- independent inverting GT that can interact with
different Rha-containing molecules.
A064R-D1D2 activity. To confirm our previous findings and expand our understanding
about A064R-D1 and A064R-D2 activities, two additional experiments were performed.
We made a recombinant protein, A064R-D1D2 (aa 1–438), similar to that encoded by the
antigenic variant CME6 virus [111], comprising D1 and D2L active domains. The first
reaction used tetrasaccharide 1 as an acceptor and two equivalents of UDP-L-Rha and
Mn2+; formation of hexasaccharide 3 was almost complete after 2 h (SI Appendix, Fig.
S10A [175]).
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The other acceptor used was monosaccharide 6 (Figure 3.1) which disclosed that
A064R-D1D2 worked also with a different D-Xyl source. The chromatographic profile
after 2 h showed that oligosaccharide 6 was replaced with trisaccharide 7 (SI Appendix,
Fig. S10B [175]), whose identity was confirmed by NMR analysis (Figure 3.1 and SI
Appendix, Fig. S11, chemical shifts in SI Appendix, Table S5 [175]), namely, that it was
6 with the α-L-Rha-(1→2)-β-L-Rha disaccharide attached to O-4 of the Xyl unit as
expected.
A064R-D1 and A064R-D2 bioinformatic analysis. Phylogenetic analysis of annotated
GT domains from characterized rhamnosyltransferases revealed that the A064R-D1 was
more like members in the GT1 family rather than the GT2 family (Figure 3.3a, detailed
list of the organisms used in SI Appendix, Table S6 [175]). However, a previous crystal
structure of A064R-D1 indicated a structural fold similar to catalytic domains of retaining
GTases in the GT-A family (characterized by a N-terminal Rossmann-like fold) [217],
although the amino acid sequence similarity was very low (less than 14% for equivalent
Cα atoms), further validating its separation from other characterized
rhamnosyltransferase proteins. An A064R-D1 pBLAST query search shows the highest
sequence similarity to hypothetical proteins from bacteria and a galactosyl transferase
domain from Burkholderia.
Interestingly, A064R-D1 shares an ancestral node of origin with eukaryotic
homologs (SI Appendix, Fig. S12A [175]). Interestingly, A064R-D2 is the most unusual
of the three A064R domains because it least resembles a recognizable GT. Its lack of
sequence homology with annotated rhamnosyltransferases (<30% with only 15%
coverage) makes it an outlier in a phylogenetic analysis that groups more closely with
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other GT2 family members rather than GT1s in the phylogenetic tree (Figure 3.3a). We
used BLASTp to further evaluate A064R-D2 (aa 213–439, SI Appendix, Fig. S1A [175]).
This domain shares limited homology with several hypothetical and uncharacterized
proteins from bacteria, including one GT-family protein from Lacipirellula parvula
(31.36% identities with 95% coverage) and two homologs in Pithovirus: a hypothetical
protein and a GT10 fucosyltransferase (>45% and >35% identities covering the Cterminal domain, respectively). The majority of A064R-D2 homologs are of bacterial
origin (SI Appendix, Fig. S12B [175]).
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Figure 3.3. Maximum-likelihood phylogenetic trees of some PBCV-1 encoded
proteins involved in glycan synthesis. Phylogenetic trees are shown for GT-associated
domains from (a) characterized rhamnosyltransferases and (b) selected MTases. (a) Tree
construction is based on GT-associated domains of virus-encoded rhamnosyltransferases
A064R-D1, A064R-D2, and a variety of annotated rhamnosyltransferases from CAZy.
(b) Tree construction is based on MT homologs of virus-encoded proteins A064R-D3 and
A061L. The branch lengths indicate evolutionary distance and are labeled with (a)
organism, residue range of GT domain, and GT family (a); and organism (b). PBCV-1
encoded proteins are in bold. The list of the organisms used along with their UniProtKB
gene accession nos. is reported in SI Appendix, Table S6 [175].

A064R-D3: SAM-Dependent methyltransferase activity. A064R-D3 (aa 439–638) is
predicted to have SAM-dependent MT activity. An A064R-D3 pBLAST query search
shows the highest sequence similarity to several hypothetical proteins from bacteria and
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many class I SAM-dependent MTases of both bacteria and virus origins (SI Appendix,
Fig. S13A [175]). Therefore, we previously hypothesized that it might add the two
methyl groups to the terminal L-Rha of the glycan [111]. To address this hypothesis, we
used the complete A064R protein because the third domain by itself did not form a
soluble recombinant protein.
Hence, A064R was incubated with 1 as the acceptor and with two equivalents of
UDP-β-L-Rha with Mn2+ and Mg2+ as the cation requirement of this domain was
unknown. Due to the labile nature of SAM, it was not possible to add two equivalents
with certainty, thus, we repeatedly added SAM until no increase in new products
occurred as judged by HPLC. The reaction produced two products (SI Appendix, Fig.
S14A [175]). The less abundant one was hexasaccharide 3 as established by its retention
time and by NMR analysis of the mixture. The NMR analysis of the most abundant
product 4 (Figure 3.1 and SI Appendix, Fig. S14 B and C and Table S7 [175]) revealed
that methylation only occurred at O-2 of the terminal α-L-Rha residue not at both O-2 and
O-3 as hypothesized.
1H-NMR

and HSQC spectra of oligosaccharide 4 (Figure 3.1 and SI Appendix,

Fig. S14 B and C [175]) revealed the same residues found in oligosaccharide 3 with H-1
of E (here, labeled E′′) slightly shifted and a new anomeric signal at 5.17 ppm, labeled as
F′, which instead replaced F. The anomeric proton of F′ had the TOCSY pattern typical
of a Rha unit, α-configured based on its C-5 value (69.5 ppm) and methylated at O-2
based on the diagnostic value of C-2 (81.2 ppm). This finding was confirmed from the
NOE contact between H-2 of F′ with the methyl group at 3.45 ppm in the T-ROESY
spectrum, which also reported that F′ was linked to O-2 of E’’ (SI Appendix, Fig. S14C
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[175]). This reaction established that the third domain of A064R only added one methyl
group to the C-2 hydroxyl group of the terminal α-L-Rha, leaving open the question about
what enzyme methylated the C-3 hydroxyl group.
A061L: Methyltransferase activity. To determine the enzyme responsible for adding a
methyl group to O-3 of the terminal α-L-Rha residue, we screened the PBCV-1 genome
for another gene encoding an O-MT. This led to the discovery of the gene a061l (SI
Appendix, Fig. S1A [175]). Phylogenetically distinct from A064R-D3 (Figure 3.3b), the
closest homolog of A061L is a macrocin-O-MT from Dishui Lake large algae virus 1. An
A061L pBLAST query search shows the highest sequence similarity to several wellcharacterized class I SAM-dependent MTases from bacteria and, although more distantly
related, from cyanobacteria and algae (SI Appendix, Fig. S13B [175]). Moreover, it had a
structural homology of 90% of the sequence modeled with 100% confidence with the OMT NovP from Streptomyces spheroids.
Recombinant A061L was tested for activity using hexasaccharides 3 or 4 as
acceptors, SAM as a donor of the methyl group, and with both Mg2+ and Mn2+. The two
acceptors differed only in the presence of the methyl group on O-2 of the terminal L-Rha
(Figure 3.1). A061L only methylated hexasaccharide 4, the substrate with the terminal LRha already possessing a methyl group at O-2 (SI Appendix, Fig. S15 [175]). No reaction
occurred with the unmethylated hexasaccharide 3. The structure of product 5 was inferred
via NMR spectroscopic analysis (SI Appendix, Fig. S16 and Table S8 [175]) which
confirmed the presence of two methyl groups (at O-2 and O-3) on the terminal L-Rha
unit. This last experiment demonstrated that the virus-encoded A061L added a methyl
group to the O-3 of the terminal L-Rha only when it was already methylated at O-2.
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However, it remains unclear if it has a cation requirement. Additional experiments will be
performed to better define all of the characteristics of this enzyme.
Modeling the two methyltransferases. The MT activity of A064R-D3 was supported by
bioinformatic information; the protein has 31.5% identity with 91% coverage (3e−19
confidence value) with a protein coded by a prokaryotic dsDNA virus sp. (UniProtKB
gene accession no. A0A516L7Y9). This viral gene encodes a putative 8-demethyl-8-α-Lrhamnosyl tetraceno-mycin-C2′-O-MT (Figure 3.3b). Moreover, a protein structure
prediction by Phyre2 analysis chose the SAM/metal-dependent O-MT MycE from
Micromonospora griseorubida to predict the 3D structure of A064R-D3 based on 178
residues (89% of the sequence modeled with 100% confidence). The choice by Phyre2 to
use this particular MT is consistent with our results.
Previously, crystal structures were determined for MycE bound to the product Sadenosyl-L-homocysteine (SAH) and Mg2+, the first structure of a natural product sugar
MT in complex with its natural substrate [219]. The structure of A064R-D3 (aa 446–638)
is predicted to accurately trace the catalytic MT domain of MycE (aa 161–399) from
residues 161–340 situated in the C terminus comprising an α/β-sandwich with a sevenstranded β-sheet core sandwiched by three α-helices on the front face and two on the
back. In agreement with other class I MTases, A064R-D3 possesses a series of conserved
motifs shared among these proteins, named motifs I–VI [220].
Notably, A064R-D3 residues 43–51 (Ile43, Ile44, Glu45, Ile46, Gly47, Ile48,
Gly49, Asp50, and Phe51) resemble motif I, a nine-residue amino acid block with the
consensus sequence (V/I/L)(L/ V)(D/E)(V/I)G(G/C)G(T/P)G. This nine-residue structure
contains the glycine-rich ‘‘GxGxG’’ signature sequon, a SAM-binding motif found in
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almost all SAM-dependent MTases. Prediction of the A064R-D3 SAM-binding sites was
corroborated by the enzyme-ligand structure model (Figure 3.4a and 3.4b). Residues
positioned within 5 Å of the SAM ligand are organized into three major regions: 46–51,
74–81, and 121–124. The predicted SAM- binding site for A064R-D3 is located within
the loops at the C-terminal end of the central β-sheet as usually occurs for methyltransferases. Prediction models detect coordination of a metal ion by homologous
residues Asp121, Glu149, and Asp150 in accord with the metal dependence of activity
observed in MycE (Asp275, Glu303, and Asp304). These residues are strictly conserved
among the MycE homologs, implying that all homologs are metal dependent. The SAM
amino acid moiety contacts Asp18 through the carboxyl group and with Asp121 and
Asp150 through the amino group. As for the metal ligands, the residues that contact SAM
are highly conserved. Protein sequence alignment of A064R-D3 and MycE displays
homology in critical functional residues (SI Appendix, Fig. S17 [175]). In total, A064RD3 has 12 of the 23 SAM-binding residues with MycE. Furthermore, active site residues
Tyr208 and His278 determined in MycE have homology with A064R-D3 residues Phe51
and His124. The single-residue substitution Y208F MycE resulted in reduced but not
abolished enzyme activity [219].
Phyre2 analysis of the SAM/metal dependent sugar O-MT NovP from S.
spheroides allowed the prediction of the 3D structure of A061L based on 188 residues
(modeled with 100% confidence). The A061L sequence contains recognizable motifs I
and II that are typical of SAM-dependent MTases (SI Appendix, Fig. S18 [175]). Motif I
lies between β1 and α4 and forms the expected interactions with the amino acyl portion
of SAM via Glu21 and Gly23, equivalent to residues Glu92 and Gly94 in NovP. Motif II,
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defined as an acidic loop, which lies at the C-terminal end of β2, forms the expected
interactions with the ribose hydroxyls groups via Asp50, equivalent to residue Asp122 in
NovP. The active center of NovP contains a strictly conserved metal-binding site
composed of three Asp residues: Asp196, Asp223, and Asp224 [221]. A further
conserved Asp198 likely acts as the general base that initiates the methyl transfer
reaction. Using in silico docking, we generated models of the A061L-SAM complex that
are consistent with this mechanism (Figure 3.4c and 3.4d). A061L possesses a
homologous three Asp sequence (Asp143, Asp170, and Asp171) and a general base
Asp145, the putative general base of the reaction, is well con- served in A061L structural
homologs. We propose this residue initiates the methyl transfer reaction by deprotonating
the C-3 hydroxyl group of the L-Rha unit.
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Figure 3.4. Stereoviews showing superpositions of methyltransferases A064R- D3
and A061L with structural homologs. (a) Superposition of predicted A064R-D3
(green) complexed with SAM (cyan) with crystalized SAM/metal-dependent sugar O-MT
MycE chain E (gray) from M. griseorubida in complex with Mg ion (magenta) and SAH
(gray). (b) Magnified view of the predicted A064R-D3 SAM-binding site. (c)
Superposition of predicted A061L (orange) complexed with SAM (cyan) with crystalized
SAM/metal-dependent sugar O-MT NovP chain A (gray) from S. spheroids in complex
with sulfate ion (red and yellow) and SAH (gray). (d) Magnified view of the predicted
A061L SAM-binding site. Residues represented by stick models are predicted to be
positioned within 5 Å of the SAM ligand and have the equivalent residue position of
ligand-binding amino acids in characterized sugar O-MT homologs. Labeled residues are
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predicted to bind SAM or metal ion via hydrogen bonding or participate in polar contact.
Bound SAM and SAH are represented by stick models.

3.2.C. Conclusions
To date, the evidence indicates that chloroviruses decorate their MCP with
atypical N-glycans [51, 107, 206] and that the viral genome encodes most, if not all, of
the enzymes responsible for synthesizing these glycans. These results support this
hypothesis by defining the activity of protein A064R, one of the GTases encoded by
chlorovirus PBCV-1, along with the function of the A061L protein encoded by another
gene a061l.
A064R (638 aa) has three functional domains of ∼200 aa each. The first two are
GTases, and the third is a MT that methylates O-2 of the terminal α-L-Rha residue. The
finding that the third domain only transfers one methyl group prompted the search for a
second virus-encoded MT, which led to the identification of A061L. This enzyme
completes the methylation of the terminal α-L-Rha by adding a methyl group to its O-3
position but only after the O-2 position has been methylated.
From a structural viewpoint, a064r encodes a rare protein because it has three
functional transferase activities: two different rhamnosyltransferases and one MT. To
date, few enzymes with multiple GT activities have been identified, and most of them
only have two functions. The oldest is KpsC, an enzyme with two GT activities that are
involved in the biosynthesis of the E. coli K5 polysaccharide [222]. More recently,
Clarke et al. [223] discovered an O2a polymerase (WbbM) in Klebsiella pneumoniae that
possesses two domains, a galactopyranosyltransferase resembling known GT8 family
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enzymes and a galactofuranosyltransferase defining a previously unrecognized family
(GT111). Only a few other multidomain enzymes have been identified with more than
one GT active site: WbdA mannosyltransferase involved in the synthesis of the E. coli
O9, O9a, and O8 lipopolysaccharide O antigens, which is recognized as a bifunctional α(1→2)-, α-(1→3)-mannosyltransferase in serotype O9a, while its counterpart in serotype
O8 is a trifunctional mannosyltransferase (α-[1→2], α-[1→3], and β-[1→2]) [224, 225].
Analyses on the O-antigenic polysaccharide produced by some isolates of Raoultella
terrigena and K. pneumoniae identified another trifunctional GT protein (WbbB), which
is able to generate a polysaccharide of [4)-α-Rha-(1→3)-β-GlcNAc-(1→] repeating units
capped with a nonreducing terminal residue of β-linked 3-deoxy-D-manno-oct-2-ulosonic
acid (β-Kdo) [226]. Other bifunctional microbial GTases are those involved in the
biosynthesis of glycosaminoglycans and glycosaminoglycan-like polysaccharides, such
as those involved in synthesis of hyaluronan [227], including one from PBCV-1 [99],
chondroitin [228], and heparosan [229], along with KpsC from E. coli K5, mentioned
above. The dGT1 enzyme from Streptococcus parasanguinis is a bifunctional protein
involved in the biosynthesis of the serine-rich repeat protein adhesin Fimbriae associate
protein (Fap1), which is essential for glycosylation of Fap1 [230]. Thus, A064R is part of
a restricted pool of GTases with three activities with the qualifier that the third domain is
a MT.
Our analysis leads to several significant conclusions: 1) PBCV-1 and probably
other chloroviruses encode multifunctional proteins involved in glycan synthesis of their
MCP glycoproteins; 2) the PBCV-1 protein A064R possesses a domain (D2) that may
represent a new GT family; 3) the A064R protein and probably other chlorovirus encoded
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GTases are likely to be soluble due to the lack of N-terminal signal peptides that target
them to the ER or the Golgi. This last conclusion suggests they may be easier to express
and purify.
Beyond the significance of our findings to chlorovirus biology, we can imagine
employing this protein or its individual domains for other purposes, e.g., the A064RD1D2 protein could be used to produce a different class of rhamnolipid biosurfactants,
having the rhamnobiose unit attached to an alkyl xyloside. Rhamnolipids are primarily
produced from some strains of Pseudomonas [231] and have multiple uses and properties
as active agents in skin re-epithelialization in wound healing [232] or used in the
cosmetics field for the treatment of wrinkles or to alleviate and/or prevent immunological
activities associated with autoimmune diseases.
In conclusion, the results described herein provide direct evidence that the
synthesis of the PBCV-1 N-glycan, or, at least, part of it, is accomplished with enzymes
encoded by the virus itself. This finding is particularly relevant as it subverts the dogma
that all viruses use host enzymes to glycosylate their proteins.
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CHAPTER IV
PBCV-1 PROTEIN A111/114R HAS THREE GLYCOSYLTRANSFERASE
ACTIVITIES INVOLVED IN GLYCAN SYNTHESIS
4.1. OVERVIEW
Interestingly, all the chloroviruses studied to date, including those with different
host specificities, have the capsid protein N-glycosylated with other types of
oligosaccharides; however, all chloroviruses share the same pentasaccharide core
oligosaccharide [51, 206] composed of an N-linked Glc, a hyperbranched Fuc, a distal
and a proximal Xyl, and a Gal (Figure 1.10). Additional monosaccharides decorate this
core N-glycan, producing a molecular signature for each chlorovirus [107]. This
oligosaccharide core was also found in all mutants (or antigenic variants) of PBCV-1
analyzed to date, except for PIL6 [111]). Mutant PIL6 is a representative of the antigenic
class D, characterized by a large genomic deletion spanning genes a014r through a078r
[111, 233]. Its N-glycan is a tetrasaccharide and is significantly truncated compared to that
of wild-type PBCV-1. It contains all the units of the chloroviruses N-glycans present in the
conserved core region except the distal Xyl attached to Fuc [107]. By analyzing the
genomes of all chloroviruses and of the mutants sequenced to date, we noted that the
a111/114r gene is the only annotated orthologous GT gene found outside of the region of
the large deletion mutants that is present in all other chloroviruses. This finding suggests its
likely involvement in the synthesis of the initial part of the unusual N-glycan shared by all
of these viruses and prompted us to investigate its role in the assemblage of the conserved
core oligosaccharide.
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4.2. GLYCOSYLTRANSFERASE A111/114R
To predict the A111/114R protein structure and functions, we used a combination
of genetic and structural analyses, together with hydrolytic activity assays and in silico
evidence by sequence analysis and protein modeling. The combined results suggest that
the A111/114R protein is a multi-domain/multi-functional GT likely involved in the
attachment of three of the five monosaccharides in the conserved core region of the Nglycan (Figure 1.10). Specifically, this large protein of 860 amino acids is comprised of
three putative domains (Figure S1 [234]; Figure 4.1), each with a specific role; the Nterminal domain (1–260 aa) is a galactosyltransferase, the central domain (261–559 aa) is
a xylosyltransferase, and the C-terminal domain (560–860 aa) is a fucosyltransferase.

D -Gal

N

D -Xyl

D1
1

L -Fuc

D2
260

D3
560

C
860

Figure 4.1. Predicted GT domains of PBCV-1 encoded protein A111/114R.
A111/114R domain analysis based on remote homology identified three putative GT
domains labeled as D1, D2, and D3, located at the N-terminal (1 to 260 aa), central (261
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to 559 aa), and C-terminal (560 to 860 aa) regions, respectively. Below individual
domains are the corresponding three-dimensional protein models assigned by Phyre2
[235] based on alignments to known protein structures identified by their PDB entry:
1GA8 Chain A (D1), 2Z86 Chain D (D2), 2NZY Chain A (D3). Protein ribbon models
are rendered using rainbow colors from N-terminus (blue) to C-terminus (red). The
putative domain, predicted protein model, and sugar substrate are connected by the black
dashes.

4.2.A. Materials and Methods
Protein modeling. The prediction of the different domains of A111/114R was performed
by HHpred [236] based on remote homology detection. Then, the 3D model of each
domain was built by Phyre2 (Protein Homology/analogY Recognition Engine V 2.0) in a
normal mode [235]. Each 3D model was based on an alignment generated by HMM–
HMM matching. Final drawings and residue analysis were prepared with the molecular
graphics system PyMol Version 1.2r3pre, Schrödinger, LLC.
Cloning and expression. PBCV-1 a111/114r and domain variants were cloned from
PCR-amplified viral DNA using oligonucleotide primers with restriction sites NotI–
BamHI. PCR fragments of the expected size were digested and inserted into the
restriction sites of the pMAL-c6T expression vector (New England Biolabs, Ipswich,
MA, USA). This process produced a maltose-binding protein (MBP) tag at the Nterminus of the target protein. The resulting plasmid was transformed into E. coli strain
One Shot TOP10 competent cells (Invitrogen) for maintenance. The E. coli cells
containing positive cloned plasmids were selected with 100 μg/mL carbenicillin. The
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cloned structure of each vector was sequence verified. Plasmids were isolated with a
QIAprep Spin Miniprep kit (Qiagen, Valencia, CA, USA) according to the
manufacturer’s instructions and transformed into NEBExpress competent cells for
expression. Viral genes were expressed by growing cells overnight at 37 °C in 10 mL of
LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L sodium chloride) containing 100
μg/mL carbenicillin. Then, 5 mL of the over-night culture was sub-cultured into 200 mL
LB medium containing 100 μg/mL carbenicillin. The batch culture was grown to an
OD600 of 0.6 at 37 °C and then induced with 0.1 mM IPTG and incubated at 16 °C
overnight. The cells were harvested by centrifugation at 3500× g, for 5 min at 4 °C, and
resuspended in 35 mL of PBS with 2 mM phenylmethylsulfonyl fluoride (PMSF). After
incubation on ice for 30 min, cells were disrupted by sonication for 3 min using a Tekmar
sonic disruptor at 30% amplitude, in 5 s pulses. Samples were centrifuged at 10,000 rpm
for 15 min to separate soluble and insoluble fractions.
Purification of recombinant enzymes. Amylose resin (New England Biolabs) was
loaded onto a 5-mL self-packing column with a 45- to 90-μm-pore-size polyethylene
filter (frit) (Life Science Products, Chestertown, MD, USA), and the resin was allowed to
settle. The column was equilibrated with 5 column volumes of cold wash buffer (50 mM
NaH2PO4, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, pH 7.2). The soluble bacterial
fraction was applied to the column and allowed to drain. The column was washed again
with 5 column volumes of cold wash buffer. The recombinant proteins were eluted with
the MBP moiety using elution buffer (wash buffer plus 10 mM maltose). The
recombinant protein concentrations were determined by a NanoDrop spectrophotometer
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(NanoDrop Technologies, Wilmington, DE, USA). Eluted proteins were resolved by
SDS-PAGE (7.5% acrylamide) with Coomassie brilliant blue staining.
UDP-GloTM and GDP-GloTM GT assays. Detection of free uridine diphosphate (UDP)
after hydrolysis of the sugar nucleotide was performed using the UDP-GloTM GT assay
kit (Promega Corporation, Madison, WI, USA), which detects UDP after UDP-sugar
hydrolysis or transfer by converting UDP to light (measured in Relative Luminescence
Units) in a luciferase-type reaction. Detection of free guanosine diphosphate (GDP) from
GDP-sugar hydrolysis was evaluated using the GDP-GloTM GT assay kit (Promega
Corporation), which operates by the same principles as above. A standard curve using 0–
25 μM of the respective nucleoside diphosphate (NDP) was performed, and the range of
measurements was determined to be in the linear range of detection, where the
luminescence detected is directly proportional to NDP concentration. Enzymes were
diluted with an optimized GT solution (0.1 M MOPS-NaOH pH 7, 10 mM Mn2+) and
supplemented with 100 μM of the targeted nucleotide sugar(s). Each sugar–nucleotide
hydrolysis reaction was incubated at 16 °C for 16 h. Following the manufacturer’s
protocol, each reaction was combined in a ratio of 1:1 (25 μL: 25 μL) with the UDPGloTM detection reagent in independent wells of a white, flat bottom 96-well assay plate
and allowed to incubate at ambient temperature. After 1 h of incubation, luminescence
was measured in triplicate, which is directly proportional to UDP or GDP concentration
based on the standard curves. Luminescence measurements were performed with a
VeritasTM microplate luminometer (Turner Biosystems, Sunnyvale, CA, USA) using a
96-well microplate with standard 128 × 86-mm geometry with an integration time of 1.0
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s. Luminescence was measured by a low-noise photomultiplier detector through an empty
filter position in the emission filter wheel.
4.2.B. Results and Discussion
In silico analysis of A111/114R domain 1. PBCV-1 encoded protein A111/114R was
annotated in NCBI (https://blast.ncbi.nlm.nih.gov/) as a hypothetical protein
(NP_048459) of which only one region was predicted to be a GT (262 to 382 aa). PSIBLAST analysis [237] revealed that A111\114R was conserved among all chloroviruses
with 62–94% sequence identity, reinforcing the notion that it could be involved in the
assembly of the conserved oligosaccharide core. Therefore, to elucidate the function of
A111\114R, we analyzed the full-protein sequence using HHpred tool [236], which
predicted three putative GT domains. N-terminal homology with several known GTases
(>98% probability) was identified for residues 1 to 256; hence, we assigned residues 1 to
260 aa as domain 1 (A111/114R-D1). The other two domains are discussed in the
following sections.
Protein structure prediction by Phyre2 analysis [235] identified six GT crystal
structures (Table S1 [234]) to model three-dimensional structures of A111/114R-D1
based on 50–82% protein coverage (>90% confidence and 12–23% sequence identity).
Models were ranked according to raw alignment score using the sequence and the
secondary structure similarity, inserts, and deletions. Interestingly, the top ranked models
were based on two xylosyltransferases (PDB:6BSV, 4WMA), one glucosyltransferase
(PDB:1LL2), and three galactosyltransferases (PDB:1GA8, 5GVV, 6U4B), in agreement
with our initial hypothesis, as both Xyl and Gal are part of the conserved region of the
core glycan (Figure 1.10). The highest ranked model was the xylosyltransferase XXT1
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from Arabidopsis (PDB: 6BSV) based on 120 residues (19% identity with 96%
confidence). However, the homologous region of A111/114R-D1 (9 to 168 aa) that
aligned with XXT1 residues 167 to 287 had no homology with the residues in the active
site of the XXT1 model, which utilized Lys-382, Asp-317, Asp-318, and Gln-319 to bind
the nucleotide sugar for catalytic activity [238]. Similarly, important residues for enzyme
activity in the xylosyltransferase XXYLT1 (PDB: 4WMA) from Mus musculus [239]
(His-262, Trp-265, and Gly-325) did not share homologous positions with A111/114RD1. Based on this evidence, we deduced that A111/114R-D1 has no xylosyltransferase
activity, and for this reason we examined the other high top ranked models, all reporting
well characterized galactosyltransferases (PDB: 1GA8, 5GVV, 6U4B), except for 1LL2
which is a glucosyltransferase involved in glycogen synthesis [240]. Although
glucosyltransferase activity cannot be definitely ruled out, A111/114R-D1 lacks the
equivalent 1LL2 residue, Tyr-194, involved in Glc addition.
In order to investigate possible galactosyltransferase activity for A111/114R-D1,
we chose, as reference protein, LgtC (1GA8), a galactosyltransferase of Neisseria
meningitidis, for which the residues involved in the sugar–nucleotide binding and in the
catalysis were well characterized. LgtC is a retaining GT that transfers α-D-Gal from
UDP-Gal to a terminal lactose. The structure of LgtC was solved in complex with Mn2+
and a non-cleavable analog of the donor sugar (UDP-Gal) in which the hydroxyl at the 2′
position of the Gal was substituted by a fluorine for stability purposes [241]. The
alignment of the protein sequences of LgtC and A111/114R-D1 (Figure 4.2), along with
the structural superimposition of the 3D model of A111/114R-D1 based on LgtC (Table
S1 [234]) with 1GA8 (Chain A) in complex with Mn2+ and an analog of the donor sugar
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(Figure 4.3), clearly revealed that all the residues responsible for binding and catalysis
were preserved. In detail, A111/114R-D1 shares four sugar binding residues with LgtC,
namely Asp-85, Asn-149, Asp-193, and Gln-194, which correspond to Asp-103, Asn153, Asp-188, and Gln-189 in LgtC (1GA8). Mutagenesis experiments have established
that LgtC Gln-189, contained within the invariant D/EQD motif found in all members of
GTases in family 8 (GT8), plays a crucial role in binding and probably in catalysis as
well [241]. A catalytic mechanism leading to the retention of the anomeric carbon
configuration for A111/114R-D1 is consistent with the presence in the oligosaccharide
core of an α-D-Gal (Figure 1.10). It has also been proven that LgtC is a cation-dependent
GT [241]. Indeed, LgtC exhibits the typical DXD motif (103DXD105), common in a wide
range of GTases, both in prokaryotes and eukaryotes [242]. In addition, a crucial role has
been attributed to Asp-103, as LgtC D103E and D103N mutants present a dramatic
reduction in their activity compared to the wild-type [241].
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Figure 4.2. Amino acid sequence alignment of A111/114R domains and known
GTases. Invariant and similar residues are highlighted in black and gray, respectively.
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Sequences from the following organisms were used (PDB code) for three individual
domains (D1, D2, and D3), respectively: (a) N. meningitidis LgtC galactosyltransferase
(1GA8), (b) E. coli K4CP dual GalNAc-transferase and GlcA-transferase (2Z86), and (c)
H. pylori fucosyltransferase (2NZW). Homologous residues positioned less than 4 Å
from the nucleotide sugar in the three-dimensional model analysis are marked with an
asterisk (*). Known residues from annotated enzymes that interact with the nucleotide
sugar donor and ion are marked with a dot (•) and underline (−), respectively. Multiple
alignment was performed by Phyre2 using structural information and homology
extension. File output was compiled by BOXSHADE.

However, the 103DXD105 motif of LgtC is not preserved in position with
A111/114R-D1, except for LgtC Asp-103, which corresponds to A111/114R-D1 Asp-85.
Homologous to residue LgtC Asp-103, Asp-85 of A111/114-D1 is positioned in close
proximity to a divalent cation and to the nucleotide sugar, as denoted with the
characteristic ligand distance < 4 A° (Table 4.1). It is likely that Asp-85 is sufficient in
providing one side-chain oxygen ligand in coordination with Mn2+, as evident from the
structural superimposition (Figure 4.3). The evidence that A111/114R-D1 possesses all
residues involved in binding and catalysis is further supported by the fact that other wellnoted galactosyltransferases exhibit similar homologies. The GT GlyE from
Streptococcus pneumoniae TIGR4 (PDB: 5GVV) binds UDP-Gal [243], and it shares the
same conserved sugar binding residues as LgtC and A111/114R-D1 (Asp-103, Asn-142,
Asp-177, and Gln-178) (Figure S2 [234]). Mutation of these key residues in GlyE
completely abolished the hydrolytic activity [243]. Additionally, the bifunctional domain
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polymerase WbbM from Klebsiella pneumoniae (PDB: 6U4B) possesses a C-terminal
galactopyranosyltransferase [244] with similar homologous residues, Asp-486 and Gln487, resembling the known GT8 family enzyme signature likely to bind UDP-Gal.

Table 4.1.
Predicted H-bond distances between homologous A111/114R residues and nucleotide–
sugar ligand
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Domain 1

Domain 2

ASN-149

Domain 3

ASP-447

ASN-749

ASP-85

TYP-755
PRO-265

ASP-351

GLN-194
ASP-193
LYS-759
ASP-353

GLU-758

Figure 4.3. Superpositions of A111/114R-D1, -D2, and -D3 with structural homologs.
Individual domains of A111/114R (cyan) are shown independently as ribbon diagrams
superimposed with known GTases (gray) bound to respective nucleotide sugars drawn as
stick models (orange) and Mn2+ ion (magenta): N. meningitidis LgtC with UDPfluorogalactose (PDB: 1GA8), E. coli K4CP with UDP-glucuronic acid (PDB: 2Z86),
and H. pylori fucosyltransferase with GDP-Fuc (PDB: 2NZY) are superposed with D1,
D2, and D3, respectively (left to right). The corresponding active sites of D1, D2, and D3
are shown magnified below the complexed stereoviews with labeled residues proposed to
be involved in sugar and ion coordination. Hydrogen bonds are represented as yellow
dotted lines.

In silico analysis of A111/114R domain 2. Three-dimensional renderings of the central
domain of A111/114R (261 to 559 aa), referred to as A111/114R-D2, were assembled
based on protein alignment and secondary structure similarities. Phyre2 analysis assigned

132
protein model predictions based on as high as 97% coverage with 100% confidence (11–
18% sequence identity) from multiple N-acetylgalactosaminyltransferases (Table S1
[234]). The top ranked model was based on the second domain of the chondroitin
polymerase K4CP from E. coli (PDB: 2Z86), namely 197 residues (66% of the protein
sequence) of A111/114R-D2 were modelled with 100% confidence. K4CP is a bifunctional enzyme organized into two GT-A domains (A1 and A2) that catalyzes
elongation of the bacterial chondroitin chain [245]. K4CP A1 (1–417) and A2 (418–682),
located respectively to the N- and C-terminal, are engaged in the transfer of GalNAc and
GlcA residues alternatively from UDP-GalNAc and UDP-GlcA. The 3D model of
A111/114R-D2 (261–474) is based on the second domain (A2) of K4CP (435 to 631 aa),
which binds UDP-GlcA, thus excluding GalNAc-transferase activity. The GlcA, absent
in the oligosaccharidic core, has the same stereochemistry of Xyl and differs from this
monosaccharide by a carboxyl function attached to carbon 5. This finding suggests that
the A111/114R-D2 could be a xylosyltransferase, and for that reason we used K4CP-A2
as a reference to assess the conservation of the residues implicated in binding and in
catalysis. Sequence alignment of A111/114R-D2 with K4CP-A2 validated the conserved
residues involved with GlcA binding and divalent cation coordination (Figure 4.2). In
detail, A111/114R-D2 residues involved in the sugar-nucleotide binding are Pro-265,
Asp-294, and Asn-323, which correspond to Pro-439, Asp-469, and Asn-496 in K4CPA2 [245]. Superposition of K4CP Chain D with the predicted A111/114R-D2 structure
(Figure 4.3) showcase these residues aligning in close proximity (<4 Å) to the nucleotide
sugar (Table 4.1), strengthening their participation in sugar-binding and catalysis. K4CP,

133
in analogy with other GT-A fold GTases, has a 519DSD521 motif coordinating the Mn2+.
This DXD motif is preserved in A111/114R-D2 and corresponds to 351DDD353.
Together, the corresponding catalytic sites and DXD motif support orthology in
enzyme activity. Of further note, two additional DXD motifs (Figure S1 [234]) are
present downstream of A111/114R-D2 (422DRD424 and 439DPD441) that potentially could
play an active role in substrate recognition or catalysis, but they do not exhibit homology
with K4CP (Figure 4.2). Should A111/114R-D2 have functional xylosyltransferase
activity, it would be the first xylosyltransferase sandwiched between two domains
specific for different nucleotide sugars. The placement of the proximal Xyl in the core
glycan structure, positioned closely to Gal and Fuc, is agreeable with the proposed
domain organization of A111/114R.
In silico analysis of A111/114R domain 3. The C-terminal domain (560 to 860 aa),
referred to as A111/114R-D3, was clearly predicted as a putative α-1,3-fucosyltransferase
(Table S1 [234]) modelled from Helicobacter pylori (PDB: 2NZW) with 100%
confidence and 15% sequence identity (86% coverage). The prediction is that Fuc is
linked to the O-3 of a Glc, which, like the monosaccharide contributions of domains D1
and D2, is a component of the overall virus core glycan structure. Fucosyltransferase
belongs to the GT B family, in which the protein contains N- and C-terminal domains
binding to the acceptor and donor substrates, respectively. Normally, these GTases do not
have a recognizable DXD motif responsible for the Mn2+/Mg2+ binding; however,
A111/114R-D3 has a 642DLD644 signature (Figure S1 [234]) that must be evaluated for
activity. A sequence alignment of A111/114R-D3 and H. pylori fucosyltransferase
(hpFucT) revealed conserved residues involved in binding of the donor substrate, GDP-
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Fuc (Figure 4.2); Asn-240, Tyr-246, Glu-249, and Lys-250 correspond to Asn-749, Tyr755, Glu-758, and Lys-759 in A111/114R-D3, respectively (Table 4.1). Classified as an
inverting GT, the proposed catalytic mechanism of hpFucT incorporates Glu-95 as a
general base in catalysis, while Lys-250 and Arg-195 in hpFucT share a key role in the
neutralization of the negative charged phosphate groups from GDP-Fuc to facilitate the
glycosidic bond cleavage [246]. Glu-249 acts to stabilize in part the positive charge
developed in the transition state as well as to form two hydrogen bonds with both the
ribose and the Fuc residues of GDP-Fuc. The Glu-95 residue of hpFucT is located in the
N-terminal domain, presumably associated with the acceptor substrate, and it has no
equivalent in A111/114R-D3. This finding could be related to alternative acceptors in the
two fucosyltransferase enzymes compared here, for example, hpFucT binding GlcNAc or
A111/114R-D3 binding Glc.
Comparison of superimposed proteins disclosed that the second half of
A111/114R-D3 traces the C-terminal domain of hpFucT Chain A (160 to 320 aa),
illustrating similarities in secondary structures. In contrast, structure resemblance
decreases towards the N-terminal regions, which could be a result of different acceptor
substrates. The open structure of the N-terminal region of the A111/114R-D3 model
could be a consequence of a larger acceptor.
To evaluate the sugar-binding and catalytic sites of A111/114R-D3, we
superimposed the domain with hpFucT (Chain A) in complex with GDP-Fuc (PDB:
2NZY). This overlap confirmed that all the expected residues involved in the GDP-Fuc
binding were preserved and in good orientation (Figure 4.3), in agreement with the
sequence alignment data (Figure 4.2). A111/114R-D3 residues Asn-749, Tyr-755, Glu-
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758, Lys-759 appeared <4 Å from the nucleotide sugar in agreement with their equivalent
residues in hpFucT (Figure 4.3). This observation suggests these A111/114R-D3 residues
likely participate in GDP-Fuc binding and are critical for A111/114R-D3 activity.
Specifically, Asn-749, Tyr-755, and Glu-758 likely stabilize the positive charge on the
Fuc moiety like their equivalent residue in hpFucT. Positioned close in proximity to
GDP-Fuc is A111/114R-D3 residue Arg-693 that corresponds to Arg-195 in hpFucT, an
essential residue for enzyme activity. In fact, Ala mutants of Arg-195 or Lys-250 resulted
in no detectable activity, supporting the idea that the two residues provide positive
charges to interact with negatively charged GDP-Fuc [246]. The important role of Arg693 is supported by its conservation amongst different chloroviruses.
In vitro evidence of A111/114R hydrolytic activity. In order to test A111/114R for GT
activity, we used the bioluminescent UDP/GDP-GloTM assays to detect free UDP/GDP
released by GT-mediated hydrolysis of the nucleotide sugars. This allowed us to screen
for nucleotide donor specificities without their target substrates (acceptor). A time course
experiment with the full-length recombinant A111/114R protein in the presence of the
core monosaccharides UDP-Gal, UDP-Xyl, GDP-Fuc, and Glc displayed evidence of
UDP-hydrolysis (Figure 4.4). Glc was supplemented to simulate the Glc-Asn acceptor
located on the nascent glycoprotein. The release of the UDP increased steadily over time,
suggestive of GT activity by A111/114R-mediated hydrolysis.
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Figure 4.4. A111/114R-catalyzed hydrolysis of UDP-sugars. Time-course experiment
with the full-length recombinant A111/114R protein (6 µg) in the optimized buffer
consisting of 0.1 M MOPS-NaOH (pH 7.0), 10 mM MgCl2, and 100 µM each of UDPGal, UDP-Xyl, GDP-Fuc, and Glc for 16 h at 16 °C. The release of UDP was detected by
the UDP-GloTM assay. Data are representative from three independent replicates, and
error bars represent standard deviation.

We recombinantly expressed the full-length A111/114R protein (1 to 860 aa) and
three variants with omitted regions (Figures 4.5a and 4.5b). A111/114R (1–397 aa)
contains the complete domain 1 and approximately the first half of domain 2, A111/114R
(266–860 aa) contains the complete domains 2 and 3, and A111/114R (391–860 aa)
contains the second half of domain 2 and the complete domain 3. Constructs containing
only individual domains were originally designed; however, their proteins did not exhibit
activity. This may reflect inaccurate residue boundaries or an incorrect folding of the
single domains in the absence of adjacent ones. Representative data from each assay are
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shown in Figure 4.5 (4.5c and 4.5d) and are represented as a ratio of the UDP or GDP
measured from reactions containing the indicated GTases relative to the full-length
protein-catalyzed hydrolysis, and negative controls in which no enzyme was added.
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Figure 4.5. Hydrolysis of UDP- and GDP-sugars by A111/114R and truncated
constructs. (a) SDS-PAGE analysis of the expressed proteins: full length recombinant
MBP-A111/114R (144 kDa), and truncated variants MBP-A111/114R (1–397) (87 kDa),
MBP-A111/114R (266–860) (110 kDa), and MBP-A111/114R (391–860) (96 kDa) were
eluted from an amylose column and resolved by SDS/PAGE with Coomassie blue
staining. BenchMarkTM pre-stained protein ladder and recombinant proteins were
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separated on a 4–20% tris-glycine gel. (b) Cartoon renderings of the full-length
A111/114R protein and truncated versions are color coordinated by three putative
domains (D1, D2, D3), each corresponding to a different nucleotide sugar donor. White
regions denote omitted sections of A111/114R. Shortened constructs are defined by their
residues in the left column. (c and d) Representative data from hydrolysis assays shown
as a ratio of the UDP (c) or GDP (d) measured from reactions containing the indicated
GTases relative to the negative controls where no enzyme was added. The release of
UDP and GDP was detected by the UDP-GloTM assay and GDP-GloTM assay,
respectively. GDP-hydrolysis from GDP-Fuc was significantly elevated in the presence
of UDP-Gal and UDP-Xyl with A111/114R (266–860) and A111/114R (391–860). Data
are representative from three replicates, and error bars represent standard deviation.

Analysis of UDP/GDP-hydrolysis by the A111/114R constructs reported in
Figure 4.5b were especially revealing in regard to A111/114R domain assignments.
Indeed, starting with the A111/114R (1–397) construct, the UDP molecules were
detected only when UDP-Gal was used (Figure 4.5c). Given A111/114R-D2 is half
omitted in A111/114R (1–397), hydrolysis of UDP-Gal implies A111/114R-D1 is a
galactosyltransferase. In agreement, no UDP was produced from UDP-Gal containing
reactions involving A111/114R constructs devoid of the first domain, A111/114R (266–
860) or A111/114R (391–860). This finding is in agreement with the bioinformatic data.
Hydrolysis of UDP-Xyl by A111/114R (266–860) suggests either A111/114R-D2
or A111/114R-D3 has xylosyltransferase activity. However, UDP-Xyl was not detected
in reactions involving A111/114R (1–397) or A111/114R (391–860), both of which are
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devoid of a complete D2 (Figure 4.5b). This suggests that A111/114R-D2 (260–560)
harbors the xylosyltransferase activity. GDP-Fuc hydrolysis was detected in reactions
involving A111/114R (266–860) and A111/114R (391–860) exclusively (Figure 4.5d).
These results suggest A111/114R-D3 is a fucosyltransferase. Notably, GDP-Fuc
reactions supplemented with UDP-Gal and UDP-Xyl showed elevated levels of liberated
GDP, especially in the presence of A111/114R (266–860). This could be a result of
improved protein folding allowed by the extension of residues and co-presence of the
nucleotide sugars.
Finally, to evaluate the residues of A111/114R involved in hydrolytic activity, we
constructed Ala mutants by site-directed mutagenesis (SDM) (GenScript) to target amino
acids from each domain predicted to be involved in nucleotide–sugar or metal–ion
binding. Three mutants were expressed, each containing two Ala substitutions inside
separate domains. A111/114R-D1, -D2, and -D3 SDM constructs contained Ala mutants
of Asp-85 and Gln-194, Asp-351 and Asp-353, and Arg-693 and Lys-759, respectively.
In the presence of UDP-Xyl, UDP-Gal, GDP-Fuc, and Glc, the SDM of D1, D2, and D3
resulted in a significant reduction in UDP-sugar hydrolysis, lowering the activity by 95%,
90%, and 80%, respectively (Figure S3 [234]). Likewise, in the presence of the same
nucleotide–sugars, GDP-Fuc hydrolysis was reduced by 90%, 70%, and 96%,
respectively. This dramatic reduction in detectable nucleotide–sugar hydrolysis supports
the idea that these residues are critical for enzyme activity, and that A111/114R functions
best when all three domains are active.
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4.2.C. Conclusions
The giant chloroviruses continue to challenge our understanding of canonical
metabolic pathways in host–virus interplay. The identification of the atypical N-glycan
structure attached to the PBCV-1 Vp54 has led to the characterization of virus-encoded
enzymes involved in glycosylation independent of host-derived ER and Golgi GTases.
The N-glycan’s core pentasaccharide conserved among the chloroviruses is especially
noteworthy and prompted us to investigate candidate virus-encoded GTases involved in
the assemblage of part or all the conserved core oligosaccharide. Results in this study
establish that PBCV-1 encoded protein A111/114R has three GT domains of
approximately 300 aa each. Evidence from a combination of amino acid alignments, three
dimensional renderings, and GT assays indicate that the N-terminal (1 to 260 aa), central
(261 to 559 aa), and the C-terminal (560 to 860 aa) regions resemble a
galactosyltransferase, a xylosyltransferase, and a fucosyltransferase, respectively. The
three-dimensional protein models built by Phyre2 are predictions and were used only for
the purpose of identifying potential individual domains. As with all methods for protein
modeling prediction, caution should be exercised when evaluating structural elements of
new enzymes that lack homology to currently deposited structures in the Protein Data
Bank archives. In fact, since the percent identity between the various domains and the
structures on which they were modeled was low, it was not possible to model the various
domains accurately. Eventually individual protein domains must be solved by
biochemical and crystallographic methods to fully reveal their catalytic mechanism.
Preliminary evidence suggests that A111/114R-D2 has xylosyltransferase activity
and, if biochemically confirmed, presents a new structural class of xylosyltransferases
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based on its limited resemblance to known xylosyltransferases. Moreover, A111/114R
would be the second three-domain protein encoded by PBCV-1 that is involved in glycan
synthesis. Indeed, recent studies showed that PBCV-1 protein A064R (638 aa) has three
functional domains; the first two are GTases (β-L-rhamnosyltransferase and α-Lrhamnosyltransferase, respectively) and the third is a MT that methylates O-2 of the
terminal α-L-Rha residue [247].
It is known that many of the chlorovirus genes encode enzymes involved in
various aspects of carbohydrate metabolism. However, it remains unclear how the virusencoded proteins are involved in the synthesis and/or assembly of the Vp54 glycan. For
example, are the sugars added to Vp54 sequentially or are they synthesized independently
of Vp54, possibly on a lipid carrier, and then attached to the protein en bloc? A slight
variation of these two possibilities is to synthesize a core glycan(s) independently of the
protein and attach it to Vp54. Additional experiments will be required to address this
issue.
Importantly, the results described herein provide support that the synthesis of the
PBCV-1 core glycan structure, or at least part of it, is accomplished with a multidomain
enzyme encoded by the virus itself. This finding is in line with the finding that another
GT of PBCV-1, the protein A064R, is able to elongate the viral glycan with two units of
Rha and to methylate the ultimate unit at O-2. Taking these finding together, the dogma
that all viruses use host enzymes to glycosylate their proteins is further subverted.
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CHAPTER V
CONCLUSIONS AND FUTURE PROSPECTS
5.1. OVERVIEW
All living cells in all domains of life are covered in glycans, typically as
glycoproteins and glycolipids. Glycans play diverse roles, including critical functions in
the areas of cell signaling, molecular recognition, immunity, and inflammation. Here, we
investigated the potential involvement of chlorovirus-encoded putative GTases and
MTases in glycosylation of the viral MCP. First, we aimed to generate site-directed virus
mutants by targeting associated viral genes. However, at present a significant barrier to
genetic transformation in chloroviruses is the recalcitrance of its host green alga making
reverse genetic manipulation of chlorovirus genomes not possible. To address these
limitations, we tested popular transformation methods using cell wall-degrading
enzymes, electroporation, SiC whiskers, cell-penetrating peptides, and Agrobacterium to
generate GT-gene mutations in the chlorovirus CA-4B. We successfully delivered
preassembled Cas9 protein-sgRNA ribonucleoproteins (RNPs) to macerozyme-treated
NC64A cells that resulted in a frameshift mutation in the CA-4B-encoded gene 034r, a
homolog of PBCV-1 GT gene a064r. Unable to duplicate these results, we shifted our
focus to characterize PBCV-1-encoded proteins involved in glycan synthesis.
We aimed to characterize chlorovirus-encoded proteins related to the synthesis of
the unusual glycans attached to the MCP of PBCV-1. Our goal was to biochemically
corroborate the involvement of virus-encoded GTases with the monosaccharides that
comprise the atypical viral N-glycans. Specifically, we tested the functional properties of
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undetermined virus-encoded proteins that are predicted to be involved in the synthesis of
its N-glycan(s) as disclosed by bioinformatic analyses. We showed that A064R has three
functional domains: domain 1 is a β-L-rhamnosyltransferase; domain 2 is an α-Lrhamnosyltransferase, and domain 3 is a MT that methylates the C-2 hydroxyl group of
the terminal α-L-Rha unit. We also established that methylation of the C-3 hydroxyl
group of the terminal α-L-Rha is achieved by another virus-encoded protein, A061L
which acts on the substrate, only if the methyl group on O-2 is already installed.
Moreover, genetic and structural analyses indicated the protein coded by PBCV-1
gene a111/114r, conserved in all chloroviruses, is a likely a GT with three putative
domains: domain 1 is a galactosyltransferase, domain 2 is a xylosyltransferase, and
domain 3 is a fucosyltransferase. Hydrolytic assays supported these predictions
suggesting that A111/114R is likely responsible for the attachment of three of the five
conserved residues of the core region of this complex glycan. These findings provide
additional support that the chloroviruses do not use the canonical host ER-Golgi
glycosylation pathway to glycosylate their glycoproteins; instead, they perform
glycosylation independent of cellular organelles using virus-encoded enzymes.
The unusual chlorovirus N-glycan structure(s) is synthesized by enzymes encoded
by the virus and does not involve the host glycosylation machinery. That is, unlike most
other viruses, the prototype chlorovirus PBCV-1 encodes most, if not all, of the
machinery required to glycosylate its MCP in the cytoplasm rather than in the ER and
Golgi that is typical for most glycoprotein-containing viruses that use host enzymes to
synthesize their glycans. This finding is particularly relevant as it challenges the dogma
that all viruses use host enzymes to glycosylate their proteins. If our predictions about
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chloroviruses are correct, investigations of these organisms will provide the field of
glycobiology with new discoveries and may ultimately answer the central question about
what benefits these viruses have by maintaining their own glycosylation machinery
through evolution. These findings could suggest an alternative virus-encoded
glycosylation pathway that perhaps pre-dates the evolution of the canonical Golgi-ER
glycosylation pathway.
Historically, GTases from eukaryotic organisms have been difficult to study
biochemically and structurally because they are membrane associated, notoriously
unstable, often contain flexible loops and domains and are commonly associated with
other interacting proteins. In contrast, as described here, GTases encoded by a group of
viruses, called chloroviruses, lack transmembrane domains because they function in the
cytoplasm of their host algae. Consequently, their recombinant proteins are soluble and
easy to work with biochemically. Our work has assisted in identifying and characterizing
many of these novel chlorovirus-encoded GTases as well as virus encoded MTases (and
possibly other modifications) that add methyl groups to specific sites on sugar molecules.
Chlorovirus-encoded GTases and MTases contribute towards the expanding repertoire of
enzymes for producing glycoconjugates that can be used in glycotechnological
applications, e.g., for creating adjuvants for vaccines, creating novel biosurfactants and
novel antibiotics. Finally, we suspect that some of the other giant viruses that are being
discovered also probably encode unique GTases. If this proves true, giant viruses will
become an extremely valuable source for new GTases.
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